Clinical Trials

• O(6)-benzylguanine and Carmustine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002604 - Completed
  unspecified adult solid tumor, protocol specific
  
• O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
  
• O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00436436 - Recruiting
  Brain and Central Nervous System Tumors
  
• O(6)-benzylguanine in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00002971 - Completed
  adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
  
• O6-benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00004892 - Completed
  Adult Oligodendroglioma; recurrent adult brain tumor; adult glioblastoma multiforme; adult ependymoma; adult anaplastic astrocytoma; ...
  
• O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
  ClinicalTrials.gov Identifier: NCT00003765 - Active, not recruiting
  recurrent childhood brain stem glioma; childhood choroid plexus tumor; recurrent childhood visual pathway glioma; ...
  
• O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00004072 - Completed
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00005066 - Active, not recruiting
  stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma
  
• O6-benzylguanine and Carmustine in Treating Patients with Unresectable Locally Recurrent or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005961 - Completed
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
  ClinicalTrials.gov Identifier: NCT00275002 - Recruiting
  Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Brain Tumor; High-Grade Childhood Cerebral Astrocytoma; ...
  
• O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003766 - Completed
  unspecified adult solid tumor, protocol specific
  
• OASIS Mechanism of Action
  ClinicalTrials.gov Identifier: NCT00570141 - Enrolling by invitation
  Diabetic Foot Ulcers; Venous Stasis Ulcers
  
• OASIS STUDY( Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)
  ClinicalTrials.gov Identifier: NCT00281034 - Completed
  Stroke
  
• Oasys vs. Extreme H20 Xtra 59
  ClinicalTrials.gov Identifier: NCT00477763 - Recruiting
  Dry Eye
  
• Oatmeal and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00401453 - Recruiting
  Diabetes Mellitus Type 2; Insulin Resistance
  
• Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00538187 - Not yet recruiting
  Lymphoma
  
• Obatoclax Mesylate and Topotecan in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00521144 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Obatoclax Mesylate, Fludarabine and Rituximab in Previously Treated Patients With B-CLL
  ClinicalTrials.gov Identifier: NCT00574938 - Recruiting
  Chronic Lymphocytic Leukemia
  
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
  ClinicalTrials.gov Identifier: NCT00577031 - Not yet recruiting
  Colorectal Cancer
  
• Obese Hypertension Study
  ClinicalTrials.gov Identifier: NCT00289887 - Active, not recruiting
  Hypertension
  
• Obese Patients with or without Comorbidities
  ClinicalTrials.gov Identifier: NCT00029861 - Completed
  Obesity; Weight Loss
  
• Obese Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00029848 - Completed
  Obesity; Diabetes Mellitus, Non-Insulin-Dependent; Obesity in Diabetes
  
• Obese Patients with Untreated Dyslipidemias
  ClinicalTrials.gov Identifier: NCT00029835 - Completed
  Obesity; Dyslipidemia
  
• Obesity and Asthma:a Specific Phenotype
  ClinicalTrials.gov Identifier: NCT00532363 - Active, not recruiting
  Obesity; Asthma
  
• Obesity and Diabetes Prevention Through Science Enrichment
  ClinicalTrials.gov Identifier: NCT00541879 - Recruiting
  Type 2 Diabetes; Obesity
  
• Obesity and Free Fatty Acid Flux
  ClinicalTrials.gov Identifier: NCT00074945 - Recruiting
  Obesity
  
• Obesity and Nonalcoholic Fatty Liver Disease
  ClinicalTrials.gov Identifier: NCT00262964 - Recruiting
  Non-Alcoholic Fatty Liver Disease
  
• Obesity and Weight Loss on Reproductive Function
  ClinicalTrials.gov Identifier: NCT00143078 - Recruiting
  Obesity; Reproductive System
  
• Obesity Assessment and Education Through the Internet
  ClinicalTrials.gov Identifier: NCT00149682 - Completed
  Obesity
  
• Obesity Intervention "Obeldicks" for Obese Children, Adolescents and Their Parents
  ClinicalTrials.gov Identifier: NCT00435734 - Recruiting
  Obesity
  
• Obesity Prevention after Smoking Cessation in Menopause
  ClinicalTrials.gov Identifier: NCT00064961 - Completed
  Obesity; Menopause
  
• Obesity Prevention for Pre-Adolescents
  ClinicalTrials.gov Identifier: NCT00185978 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Obesity Prevention in African American School Children
  ClinicalTrials.gov Identifier: NCT00061165 - Completed
  Obesity
  
• Obesity Treatment in a Managed Care Setting
  ClinicalTrials.gov Identifier: NCT00062985 - Completed
  Obesity; Weight Loss
  
• Obesity, Physical Inactivity or Dietary Fat ?
  ClinicalTrials.gov Identifier: NCT00434265 - Not yet recruiting
  Obesity
  
• Obesity, Weight Loss, and Cardiovascular Disease Risk
  ClinicalTrials.gov Identifier: NCT00186459 - Recruiting
  Obesity
  
• Objective Evaluation of Proximal Ischemia
  ClinicalTrials.gov Identifier: NCT00152737 - Recruiting
  Intermittent Claudication; Peripheral Vascular Diseases
  
• Objective Evaluation of Shoulder Pathology and Surgery
  ClinicalTrials.gov Identifier: NCT00500630 - Completed
  Glenohumeral Osteoarthritis; Rotator Cuff Disease
  
• Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
  ClinicalTrials.gov Identifier: NCT00567177 - Recruiting
  Treatment of Dry Eye Disease
  
• Objective Sleep Disturbances in Orthostatic Intolerance
  ClinicalTrials.gov Identifier: NCT00581022 - Recruiting
  Postural Tachycardia Syndrome; Chronic Orthostatic Intolerance
  
• Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301
  ClinicalTrials.gov Identifier: NCT00070343 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma
  
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00047229 - Active, not recruiting
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
  ClinicalTrials.gov Identifier: NCT00060112 - Suspended
  adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma
  
• Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00017589 - Active, not recruiting
  recurrent adult acute myeloid leukemia
  
• Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00091078 - Active, not recruiting
  gastrointestinal stromal tumor
  
• Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Oblimersen and Rituximab in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00054639 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Oblimersen in Treating Patients With Metastatic or Recurrent Merkel Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00079131 - Completed
  recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma; stage III Merkel cell carcinoma
  
• Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00021190 - No longer recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00062244 - Completed
  Waldenstrom's Macroglobulinemia
  
• Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00039481 - Completed
  cardiac toxicity; unspecified childhood solid tumor, protocol specific
  
• Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00063934 - Active, not recruiting
  stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; Male Breast Cancer
  
• Oblimersen Plus Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00049192 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia
  
• Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00039117 - Active, not recruiting
  untreated adult acute myeloid leukemia; secondary acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); ...
  
• Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00086944 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent grade 3 follicular lymphoma
  
• Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00070083 - Completed
  contiguous stage II adult diffuse large cell lymphoma; noncontiguous stage II adult diffuse large cell lymphoma; ...
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Observation and Evaluation of Chewing Velocity Changes on Soft Food Chewing Efficiency
  ClinicalTrials.gov Identifier: NCT00172692 - Completed
  Healthy; Mastication
  
• Observation and Prediction of Complications After Coronary Angiography
  ClinicalTrials.gov Identifier: NCT00259194 - Active, not recruiting
  Coronary Arteriosclerosis; Myocardial Ischemia
  
• Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00274950 - Recruiting
  Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer
  
• Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
  ClinicalTrials.gov Identifier: NCT00400907 - Active, not recruiting
  Long-Term Effects Secondary to Cancer Therapy in Adults; Lymphoma
  
• Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
  ClinicalTrials.gov Identifier: NCT00001826 - Completed
  HIV Infection
  
• Observation of Respiration Following Regional Anaesthesia With Intrathecal Opioids for Caesarean Section
  ClinicalTrials.gov Identifier: NCT00544947 - Not yet recruiting
  Respiratory Depression
  
• Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
  ClinicalTrials.gov Identifier: NCT00258453 - Active, not recruiting
  Brain and Central Nervous System Tumors; Long-Term Effects Secondary to Cancer Therapy in Children; Perioperative/Postoperative Complications; Psychosocial Effects/Treatment; Quality of Life; Weight Changes
  
• Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
  ClinicalTrials.gov Identifier: NCT00416559 - Active, not recruiting
  Long-Term Effects Secondary to Cancer Therapy in Children; Neuroblastoma
  
• Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
  ClinicalTrials.gov Identifier: NCT00027846 - Active, not recruiting
  childhood supratentorial ependymoma; newly diagnosed childhood ependymoma; childhood infratentorial ependymoma
  
• Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003375 - Active, not recruiting
  Adult Oligodendroglioma; adult noninfiltrating astrocytoma; adult infiltrating astrocytoma
  
• Observation or Radical Treatment in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00499174 - Recruiting
  Prostate Cancer
  
• Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
  ClinicalTrials.gov Identifier: NCT00193661 - Completed
  Primary or Secondary Hypogonadism; Constitutional Delay in Growth and Puberty (CDGP)
  
• Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00410631 - Recruiting
  Brain and Central Nervous System Tumors
  
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00346164 - Recruiting
  Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
  
• Observational Aspirin Use and CVD in the Physicians' Health Study
  ClinicalTrials.gov Identifier: NCT00005493 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Cerebrovascular Accident
  
• Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS
  ClinicalTrials.gov Identifier: NCT00316732 - Active, not recruiting
  Benign Prostatic Hyperplasia
  
• Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
  ClinicalTrials.gov Identifier: NCT00433030 - Recruiting
  HIV Infections
  
• Observational Cohort Study of Sodium, Weight and CVD
  ClinicalTrials.gov Identifier: NCT00006308 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Observational Cohort Study of TachoSil
  ClinicalTrials.gov Identifier: NCT00285623 - Active, not recruiting
  Blood Loss, Surgical
  
• Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products
  ClinicalTrials.gov Identifier: NCT00388947 - Recruiting
  Vaginal Prolapse
  
• Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury
  ClinicalTrials.gov Identifier: NCT00498498 - Recruiting
  Cerebrovascular Trauma; Neurohormones; Cellular Apoptosis; Endothelin System
  
• Observational FAP Registry Study
  ClinicalTrials.gov Identifier: NCT00151476 - Recruiting
  Adenomatous Polyposis Coli
  
• Observational Learning in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00083642 - Active, not recruiting
  
  
• Observational Non-Interventional Study (Anwendungsbeobachtung) With Aptivus? (Tipranavir) in HIV-Infected Patients.
  ClinicalTrials.gov Identifier: NCT00531206 - Recruiting
  HIV Infections
  
• Observational Non-Interventional Study (Anwendungsbeobachtung) With Telmisartan in High-Risk Hypertensives
  ClinicalTrials.gov Identifier: NCT00539487 - Recruiting
  Hypertension; Obesity
  
• Observational Non-Interventional Study With Spiriva in COPD Patients With Exercise-Induced Dyspnoea
  ClinicalTrials.gov Identifier: NCT00540163 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Observational Non-Interventional Study With Viramune? in Combination With Truvada? in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00543803 - Recruiting
  HIV Infections
  
• Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
  ClinicalTrials.gov Identifier: NCT00358813 - Recruiting
  Renal Impairment
  
• Observational Safety Study of Enbrel for Treatment of Psoriasis
  ClinicalTrials.gov Identifier: NCT00322439 - Completed
  Psoriasis
  
• Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
  ClinicalTrials.gov Identifier: NCT00359177 - Completed
  Renal Impairment
  
• Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)
  ClinicalTrials.gov Identifier: NCT00242840 - Completed
  HIV Infections
  
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00259909 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
  ClinicalTrials.gov Identifier: NCT00549952 - Recruiting
  Oral Mucositis
  
• Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00331448 - Active, not recruiting
  HIV Infections; Lipodystrophy; Diabetes; Hyperlipidemia; Atherosclerosis
  
• Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  ClinicalTrials.gov Identifier: NCT00119405 - Recruiting
  HIV Infections; Lipodystrophy; Metabolic Diseases; Nutrition Disorders
  
• Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide
  ClinicalTrials.gov Identifier: NCT00202657 - Active, not recruiting
  Parkinson's Disease; Pergolide
  
• Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
  ClinicalTrials.gov Identifier: NCT00514098 - Not yet recruiting
  HIV Infections
  
• Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
  ClinicalTrials.gov Identifier: NCT00321438 - Terminated
  HIV Infections
  
• Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year
  ClinicalTrials.gov Identifier: NCT00550069 - Not yet recruiting
  Respiratory Distress; Hypoglycemia; Feeding Intolerance; Jaundice; Hypothermia; Developmental Delay
  
• Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
  ClinicalTrials.gov Identifier: NCT00569907 - Recruiting
  Diabetes Mellitus Type 2
  
• Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients
  ClinicalTrials.gov Identifier: NCT00338234 - Recruiting
  Anemia; Intensive Care; Cardiac Surgery
  
• Observational Study of Lamotrigine
  ClinicalTrials.gov Identifier: NCT00299793 - Completed
  Epilepsy
  
• Observational Study of Pergolide Mesylate and Cardiac Valvulopathy
  ClinicalTrials.gov Identifier: NCT00311532 - Completed
  Parkinson Disease
  
• Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve
  ClinicalTrials.gov Identifier: NCT00329667 - Active, not recruiting
  Valvular Heart Disease
  
• Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
  ClinicalTrials.gov Identifier: NCT00258869 - Recruiting
  Sepsis; Septicemia; Sepsis Syndrome; Shock, Septic; Pneumonia
  
• Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.
  ClinicalTrials.gov Identifier: NCT00158717 - Active, not recruiting
  Hepatitis B
  
• Observational Study of the Prognosis in Treated Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00225030 - Completed
  Hypertension
  
• Observational Study of the Remodelling Process Following Myocardial Infarct
  ClinicalTrials.gov Identifier: NCT00338156 - Completed
  Heart Failure; Myocardial Infarct
  
• Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00219934 - Recruiting
  HIV Infections
  
• Observational Study Regarding Adherence, Drug Use, Will to Take Part in Shared Decisioning in Asthma Outpatients
  ClinicalTrials.gov Identifier: NCT00557141 - Not yet recruiting
  Asthma
  
• Observational Study to Determine Impact of Multiple NAb Tests on Treatment Patterns Compared to the Usual Care of MS Patients Receiving High-Dose IFN Therapy.
  ClinicalTrials.gov Identifier: NCT00336557 - Recruiting
  Multiple Sclerosis
  
• Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe
  ClinicalTrials.gov Identifier: NCT00457275 - Completed
  Hypercholesterolemia
  
• Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
  ClinicalTrials.gov Identifier: NCT00244465 - Recruiting
  Narcolepsy
  
• Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
  ClinicalTrials.gov Identifier: NCT00347217 - Recruiting
  Hypercholesteremia
  
• Observational Trial With Enbrel
  ClinicalTrials.gov Identifier: NCT00488475 - Recruiting
  Rheumatoid Arthritis
  
• Observational Trial With Leios/Alesse
  ClinicalTrials.gov Identifier: NCT00481650 - Completed
  Contraceptives, Oral, Combined
  
• Observing Patients with Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00005020 - Active, not recruiting
  HIV Infections
  
• Obstetrics and Periodontal Therapy (OPT) Study
  ClinicalTrials.gov Identifier: NCT00066131 - Active, not recruiting
  Periodontitis; Infant, Premature
  
• Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative Stress
  ClinicalTrials.gov Identifier: NCT00177892 - Recruiting
  Obstructive Sleep Apnea; Metabolic Syndrome X
  
• Obstructive Sleep Apnea Syndrome in Glaucoma
  ClinicalTrials.gov Identifier: NCT00313092 - Recruiting
  Obstructive Sleep Apnoe Syndrome; Glaucoma
  
• Obtain a Good Blood Glucose Control With the Paradigm Real Time System
  ClinicalTrials.gov Identifier: NCT00441129 - Recruiting
  Type 1 Diabetes
  
• Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
  ClinicalTrials.gov Identifier: NCT00200109 - Active, not recruiting
  Chronic Migraine Headache
  
• Occipital Nerve Stimulation to Treat Chronic Headaches
  ClinicalTrials.gov Identifier: NCT00205894 - Active, not recruiting
  Headache Disorders
  
• Occluded Artery Trial (OAT)
  ClinicalTrials.gov Identifier: NCT00004562 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart Failure, Congestive; Heart Failure
  
• Occupation and Asthma in an Urban Low Income Population
  ClinicalTrials.gov Identifier: NCT00014820 - Completed
  Asthma; Lung Diseases
  
• Occupational Therapy to Treat Children Who Over or Under React to Their Environment
  ClinicalTrials.gov Identifier: NCT00006507 - Completed
  Sensory Disorders
  
• Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the Highly Active Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00516581 - Completed
  Pneumocystis Pneumonia; HIV Infections
  
• OCD Among Patients With Burns
  ClinicalTrials.gov Identifier: NCT00294983 - Suspended
  Obsessive-Compulsive Dosorder; Burns
  
• OCSTUD Docetaxel+Cisplatin+Cyclophosphamide Versus Docetaxel+Carboplatin in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00452985 - Active, not recruiting
  Ovarian Neoplasms
  
• OCT for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00581503 - Enrolling by invitation
  Lung Cancer; Pleural Cancer; Prostate Cancer
  
• Octanol to Treat Essential Tremor
  ClinicalTrials.gov Identifier: NCT00080366 - Completed
  Essential Tremor
  
• Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00008073 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
  ClinicalTrials.gov Identifier: NCT00569127 - Not yet recruiting
  Head and Neck Cancer; Islet Cell Tumor; Neuroendocrine Carcinoma of the Skin
  
• Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004895 - Completed
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer
  
• Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00332696 - Active, not recruiting
  Peritoneal Neoplasms; Intestinal Obstruction; Carcinomatosis
  
• Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003057 - Active, not recruiting
  Colon Cancer; Diarrhea; Rectal Cancer
  
• Octreotide Efficacy and Safety in First-Line Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00171886 - Suspended
  Acromegaly
  
• Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
  ClinicalTrials.gov Identifier: NCT00033605 - Active, not recruiting
  adult solid tumor; Diarrhea; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; male reproductive cancer
  
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00075868 - Active, not recruiting
  Anal Cancer; Drug Toxicity; radiation enteritis; Rectal Cancer
  
• Octreotide in Severe Polycystic Liver Disease
  ClinicalTrials.gov Identifier: NCT00426153 - Recruiting
  Polycystic Kidney, Autosomal Dominant; Hepatomegaly; Liver Diseases; Kidney, Polycystic; Abdominal Pain
  
• Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00006269 - Active, not recruiting
  recurrent colon cancer; Diarrhea; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Octreotide in Treating Patients With Cancer-Related Malignant Ascites
  ClinicalTrials.gov Identifier: NCT00182754 - Recruiting
  unspecified adult solid tumor, protocol specific; malignant ascites
  
• Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00257426 - Active, not recruiting
  Liver Cancer
  
• Octreotide Therapy in Children With Prader-Willi Syndrome (PWS)
  ClinicalTrials.gov Identifier: NCT00399893 - Recruiting
  Prader-Willi Syndrome
  
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
  ClinicalTrials.gov Identifier: NCT00003283 - Active, not recruiting
  recurrent malignant thymoma; invasive malignant thymoma
  
• Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002967 - Completed
  stage I breast cancer; invasive ductal breast carcinoma; stage II breast cancer
  
• Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment with Dorzolamide
  ClinicalTrials.gov Identifier: NCT00152932 - Recruiting
  Laser-Doppler Flowmetry
  
• Ocular Hypertension Treatment Study (OHTS)
  ClinicalTrials.gov Identifier: NCT00000125 - Active, not recruiting
  Ocular Hypertension; Glaucoma
  
• Ocular Hypotensive Efficacy of AR-102
  ClinicalTrials.gov Identifier: NCT00523250 - Recruiting
  Glaucoma
  
• Ocular Ischemic Syndrome
  ClinicalTrials.gov Identifier: NCT00403195 - Recruiting
  Retinal Degeneration; Diabetic Retinopathy
  
• Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00356850 - Completed
  Eye Infections, Bacterial
  
• Ocular Pulse Amplitude And Choroidal Laser Doppler Flowmetry
  ClinicalTrials.gov Identifier: NCT00409110 - Recruiting
  Healthy
  
• Ocular Surface Changes in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00345280 - Not yet recruiting
  Eye Manifestations
  
• Ocular Tolerance and IOP Effects of Zylet vs Tobradex
  ClinicalTrials.gov Identifier: NCT00532961 - Completed
  Ocular Inflammation
  
• Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00357292 - Completed
  Eye Infections, Bacterial
  
• Oculusgen (Ologen) Collagen Matrix Safety and Effective Comparision With MMC in Glaucoma Surgery
  ClinicalTrials.gov Identifier: NCT00538590 - Recruiting
  Open Angle Glaucoma
  
• Oculusgen (Ologen) Glaucoma MMC Control in Estonia
  ClinicalTrials.gov Identifier: NCT00524758 - Recruiting
  Open Angle Glaucoma; Angle Closure Glaucoma; Uveitis Glaucoma; Young Age Glaucoma; Neovascular Glaucoma; High Risk Patient
  
• OculusGen-Glaucoma Historical Control Study in Taiwan
  ClinicalTrials.gov Identifier: NCT00406822 - Recruiting
  Glaucoma
  
• OculusGen-Phacotrabeculectomy Historical Control Study in India
  ClinicalTrials.gov Identifier: NCT00477685 - Recruiting
  Glaucoma; Cataract
  
• OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00449722 - Completed
  Ulcerative Colitis
  
• Odense Androgen Study
  ClinicalTrials.gov Identifier: NCT00150163 - Active, not recruiting
  Bone Diseases; Lipid and glucose metabolism
  
• Odense Androgen Study in the Elderly
  ClinicalTrials.gov Identifier: NCT00155961 - Completed
  Bone Diseases; Metabolic Syndrome
  
• Odiparcil For The Prevention Of Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00244725 - Active, not recruiting
  Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism
  
• Odiparcil QT Definitive Study
  ClinicalTrials.gov Identifier: NCT00437242 - Terminated
  Atrial Fibrillation
  
• ODYSSEY Study: Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00174863 - Completed
  Prostatic Neoplasm
  
• Oestrogen Withdrawal in Hypopituitary Women
  ClinicalTrials.gov Identifier: NCT00572390 - Completed
  Hypopituitarism
  
• Ofatumumab (Humax-CD20) With CHOP in FL Patients
  ClinicalTrials.gov Identifier: NCT00494780 - Recruiting
  Follicular Lymphoma
  
• Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients
  ClinicalTrials.gov Identifier: NCT00410163 - Recruiting
  B-Cell Chronic Lymphocytic Leukemia
  
• Off Label Use of INFLIXIMAB in Adult Patients With Severe Eosinophilic Esophagitis
  ClinicalTrials.gov Identifier: NCT00523354 - Completed
  Esophagitis
  
• Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
  ClinicalTrials.gov Identifier: NCT00344617 - Active, not recruiting
  Choroidal Neovascularisation; Polypoidal Choroidal Vasculopathy
  
• Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00380679 - Active, not recruiting
  High Risk for Serious Influenza; High Risk for Pneumonia
  
• Office Practice Assessment of Carotid Atherosclerosis Using Handheld Ultrasound (OPACA) Study
  ClinicalTrials.gov Identifier: NCT00258973 - Completed
  Atherosclerosis
  
• Office-Based Asthma Screening Intervention
  ClinicalTrials.gov Identifier: NCT00156468 - Completed
  Asthma
  
• Official Record of Patients Diagnosed with Lymphangioleiomyomatosis (LAM)
  ClinicalTrials.gov Identifier: NCT00001869 - Completed
  Leiomyomatosis
  
• Ofloxacin vs. Gentamicin as Prophylaxis Prior Transrectal Biopsy of Prostate
  ClinicalTrials.gov Identifier: NCT00480376 - Not yet recruiting
  Infection
  
• OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients with Neuronopathic Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00041535 - Active, not recruiting
  Gaucher Disease
  
• OGT Spray in the Management of Xerostomia in the Elderly
  ClinicalTrials.gov Identifier: NCT00350350 - Terminated
  Xerostomia
  
• OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00471432 - Completed
  Bladder Cancer; Breast Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00258375 - Active, not recruiting
  Breast Cancer
  
• Olanzapine Augmentation Therapy in Treatment-Resistant Depression: a Double-Blind Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00273624 - Recruiting
  Therapy-Resistant Depression
  
• Olanzapine Compared to Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00094549 - Completed
  Bipolar Disorder
  
• Olanzapine in Patients With Advanced Cancer and Weight Loss
  ClinicalTrials.gov Identifier: NCT00489593 - Recruiting
  Advanced Cancer; Weight Loss
  
• Olanzapine in Patients with Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00091650 - Completed
  Borderline Personality Disorder
  
• Olanzapine in the Treatment of Hair Pulling (Trichotillomania)
  ClinicalTrials.gov Identifier: NCT00182507 - Completed
  Trichotillomania
  
• Olanzapine in the Treatment of Patients With Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00260962 - Recruiting
  Anorexia Nervosa
  
• Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320489 - Recruiting
  Schizophrenia
  
• Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
  ClinicalTrials.gov Identifier: NCT00190892 - Completed
  Bipolar Disorder
  
• Olanzapine Treatment of Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00510146 - Recruiting
  Depression, Bipolar
  
• Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00034580 - Completed
  Bipolar Disorder
  
• Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00034801 - Completed
  Depression; Schizophrenia; Schizoaffective Disorder
  
• Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00036088 - Completed
  Schizophrenia
  
• Olanzapine versus Aripiprazole in the Treatment of Acutely Ill Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00103571 - Completed
  Schizophrenia
  
• Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia
  ClinicalTrials.gov Identifier: NCT00179231 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Olanzapine Versus Comparator in the Treatment of Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00485680 - Completed
  Bipolar Disorder
  
• Olanzapine versus Placebo in the Treatment of Adolescents with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00051298 - Completed
  Schizophrenia
  
• Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00050206 - Completed
  Bipolar Disorder
  
• Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
  ClinicalTrials.gov Identifier: NCT00485771 - Completed
  Bipolar Disorder
  
• Older Adult Training Study With Creatine and CLA
  ClinicalTrials.gov Identifier: NCT00473902 - Completed
  Sarcopenia
  
• Older Men and Testosterone
  ClinicalTrials.gov Identifier: NCT00119483 - Active, not recruiting
  Hypogonadism
  
• OLES
  ClinicalTrials.gov Identifier: NCT00172133 - Active, not recruiting
  Osteoporosis
  
• Olestra Containing Foods and Weight Loss and Weight Maintenance
  ClinicalTrials.gov Identifier: NCT00198965 - Completed
  Obesity
  
• Oligodendrocyte Progenitor Cell Culture From Human Brain
  ClinicalTrials.gov Identifier: NCT00283023 - Not yet recruiting
  Demyelinating Diseases
  
• Olive Oil With Omega 3 to Treat Stasis Dermatitis
  ClinicalTrials.gov Identifier: NCT00421161 - Not yet recruiting
  Dermatitis
  
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00139698 - Completed
  Essential Hypertension
  
• Olmesartan and an Add-on Treatment in Patients With Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00311155 - Recruiting
  Essential Hypertension
  
• OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
  ClinicalTrials.gov Identifier: NCT00134160 - Active, not recruiting
  Aged; Hypertension; Diabetes Mellitus Type 2; Cardiovascular Diseases
  
• Olmesartan as an Add-on to Amlodipine in Hypertension
  ClinicalTrials.gov Identifier: NCT00220233 - Completed
  Essential Hypertension
  
• Olmesartan in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00185172 - Active, not recruiting
  Essential Hypertension
  
• Olmesartan Medoxomil and Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00362960 - Completed
  Type 2 Diabetes Mellitus; Diabetic Nephropathy; Proteinuria; Renal Disease
  
• Olmesartan Medoxomil in Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00185185 - Completed
  Essential Hypertension; Atherosclerotic Cardiovascular Disease
  
• Olmesartan Medoxomil in Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00185159 - Active, not recruiting
  Diabetes Mellitus, Type 2; Cardiovascular Disease; Kidney Disease
  
• Olmesartan Medoxomil in Hypertension and Renal Impairment
  ClinicalTrials.gov Identifier: NCT00151827 - Completed
  Essential Hypertension; Renal impairment
  
• Olmesartan Pediatric Pharmacokinetic (PK) Study
  ClinicalTrials.gov Identifier: NCT00151814 - Recruiting
  Hypertension
  
• Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00441350 - Not yet recruiting
  Hypertension
  
• Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital
  ClinicalTrials.gov Identifier: NCT00321035 - Active, not recruiting
  Glaucoma; Pterygium
  
• Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital
  ClinicalTrials.gov Identifier: NCT00320762 - Active, not recruiting
  Glaucoma; Pterygium
  
• Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
  ClinicalTrials.gov Identifier: NCT00320957 - Completed
  Glaucomas; Pterygium
  
• Ologen (OculusGen)-Glaucoma Case Control Trial in India
  ClinicalTrials.gov Identifier: NCT00448929 - Recruiting
  Glaucoma
  
• Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
  ClinicalTrials.gov Identifier: NCT00472810 - Recruiting
  Glaucoma; Trabeculectomy
  
• Ologen (OculusGen)-Glaucoma MMC Control Trial in India
  ClinicalTrials.gov Identifier: NCT00449098 - Recruiting
  Glaucoma
  
• Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital
  ClinicalTrials.gov Identifier: NCT00478790 - Recruiting
  Glaucomas; Pterygium
  
• Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00331500 - Active, not recruiting
  Allergic Conjunctivitis
  
• Oltipraz in the Prevention of Lung Cancer in People Who Smoke
  ClinicalTrials.gov Identifier: NCT00006457 - Active, not recruiting
  Small Cell Lung Cancer; prevention of lung cancer; Non-small cell lung cancer
  
• Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment
  ClinicalTrials.gov Identifier: NCT00296153 - Recruiting
  Human Immunodeficiency Virus; Ischemic Heart Disease
  
• Omacor and Placebo in Carotid Plaque Stability
  ClinicalTrials.gov Identifier: NCT00294216 - Completed
  Cardiovascular Disease
  
• Omacor for Perimenopausal Depression
  ClinicalTrials.gov Identifier: NCT00517972 - Recruiting
  Depression
  
• Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00328536 - Not yet recruiting
  Atherosclerosis; Type 2 Diabetes Mellitus
  
• Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
  ClinicalTrials.gov Identifier: NCT00257283 - Completed
  Kidney Failure, Chronic
  
• Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
  ClinicalTrials.gov Identifier: NCT00078195 - Completed
  Hay Fever; Hypersensitivity; Allergy; Rhinitis
  
• Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00264849 - Recruiting
  Asthma
  
• Omalizumab to Treat Eosinophilic Gastroenteritis
  ClinicalTrials.gov Identifier: NCT00084097 - Active, not recruiting
  Gastroenteritis
  
• Omalizumab to Treat Hyper-IgE (Job's) Syndrome
  ClinicalTrials.gov Identifier: NCT00260702 - Recruiting
  Hyper-IgE Syndrome; Job's Syndrome
  
• Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00567476 - Recruiting
  Asthma
  
• Omega 3 Fatty Acids and Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00508248 - Recruiting
  Atrial Fibrillation
  
• Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
  ClinicalTrials.gov Identifier: NCT00467818 - Recruiting
  Autism
  
• Omega 3 PUFAs and Microvolt TWA in Patients With Ventricular Arrhythmia
  ClinicalTrials.gov Identifier: NCT00507390 - Recruiting
  Defibrillators, Implantable
  
• Omega Interferon Alone or in Combination with Ribavirin in Subjects with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00097045 - Completed
  Hepatitis C
  
• Omega-3 and Vitamin E Supplementation in Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00399282 - Completed
  Rheumatoid Arthritis
  
• Omega-3 Fatty Acid Status in Morbid Obesity Before and After Surgical Treatment
  ClinicalTrials.gov Identifier: NCT00558532 - Recruiting
  Morbid Obesity; Cardiovascular Disease; Fatty Acid Levels
  
• Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
  ClinicalTrials.gov Identifier: NCT00135902 - Active, not recruiting
  Preterm Birth; Pregnancy
  
• Omega-3 Fatty Acid Treatment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00360906 - Completed
  Relapsing-Remitting Multiple Sclerosis
  
• Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery
  ClinicalTrials.gov Identifier: NCT00488904 - Recruiting
  Complications; Infections; Colorectal Cancer
  
• Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00511810 - Recruiting
  Major Depressive Disorder; Neuroimaging
  
• Omega-3 Fatty Acids for High Triglycerides in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00346697 - Recruiting
  HIV; AIDS; Dyslipidemia; Hypertriglyceridemia
  
• Omega-3 Fatty Acids for Treating Adults With Major Depression
  ClinicalTrials.gov Identifier: NCT00517036 - Recruiting
  Depression
  
• Omega-3 Fatty Acids in Adolescent Depression
  ClinicalTrials.gov Identifier: NCT00312897 - Recruiting
  Adolescent Depression
  
• Omega-3 fatty acids in bipolar disorder
  ClinicalTrials.gov Identifier: NCT00010868 - Completed
  Bipolar Disorder
  
• Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00252486 - Active, not recruiting
  Bipolar Disorder
  
• Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00114296 - Active, not recruiting
  Breast Cancer
  
• Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00001146 - Completed
  Bipolar Disorder; Involutional Depression; Mood Disorder
  
• Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss
  ClinicalTrials.gov Identifier: NCT00003077 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Omega-3 Fatty Acids that Affect the Immune System in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00047983 - Completed
  Kidney Diseases
  
• Omega-3 for Depression and Other Cardiac Risk Factors
  ClinicalTrials.gov Identifier: NCT00116857 - Recruiting
  Cardiovascular Diseases; Depression; Heart Diseases; Myocardial Infarction; Angina, Unstable
  
• Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00149409 - Recruiting
  Chronic Heart Failure
  
• Omega-Three Fatty Acids for the Prevention of Atrial Fibrillation After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00446966 - Recruiting
  Atrial Fibrillation
  
• OmegAD (Omega-3 and Alzheimer's Disease)
  ClinicalTrials.gov Identifier: NCT00211159 - Completed
  Alzheimer's Disease
  
• Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.
  ClinicalTrials.gov Identifier: NCT00172198 - Recruiting
  Critical Ill Patients in SICU
  
• Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial)
  ClinicalTrials.gov Identifier: NCT00412256 - Completed
  Rheumatoid Arthritis
  
• Omentectomy for the Treatment of Diabetes Mellitus Type 2
  ClinicalTrials.gov Identifier: NCT00270439 - Active, not recruiting
  Diabetes Mellitus Type 2; Dyslipidemia; Hypercholesterolemia; Obesity
  
• Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
  ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
  Gastric Cancer; Precancerous Condition
  
• Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-Adjusted Dosing
  ClinicalTrials.gov Identifier: NCT00537732 - Recruiting
  Gastroesophageal Reflux
  
• OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
  ClinicalTrials.gov Identifier: NCT00277524 - Active, not recruiting
  Tachycardia, Ventricular; Heart Failure, Congestive; Ventricular Fibrillation; Ventricular Dysfunction; Bradycardia
  
• Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
  ClinicalTrials.gov Identifier: NCT00478556 - Recruiting
  Healthy
  
• Omr-IgG-am™ (Trademark) for Treating Patients with or at High Risk for West Nile Virus Disease
  ClinicalTrials.gov Identifier: NCT00069316 - Active, not recruiting
  West Nile Virus
  
• On Demand Treatment of Reflux Disease
  ClinicalTrials.gov Identifier: NCT00184522 - Completed
  Gastroesophageal Reflux
  
• On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)
  ClinicalTrials.gov Identifier: NCT00564460 - Not yet recruiting
  Benign Prostatic Hyperplasia
  
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
  ClinicalTrials.gov Identifier: NCT00161096 - Active, not recruiting
  Chronic Use of Acid Suppressive Medication; GORD; GERD; Reflux; Peptic Ulcer
  
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
  ClinicalTrials.gov Identifier: NCT00256828 - Completed
  HIV Infections
  
• Once Daily 3TC, Efavirenz and ddI for HIV Infection
  ClinicalTrials.gov Identifier: NCT00214435 - Recruiting
  HIV Infection; AIDS
  
• Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART
  ClinicalTrials.gov Identifier: NCT00196612 - Completed
  HIV Infections
  
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00413374 - Recruiting
  Deep Vein Thrombosis; Pulmonary Embolism
  
• Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00343850 - Terminated
  Ulcerative Colitis
  
• Once Weekly Parathyroid Hormone for Osteoporosis
  ClinicalTrials.gov Identifier: NCT00065637 - Completed
  Osteopenia; Osteoporosis
  
• Once Weekly Radiation for Lung Cancer With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00256789 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Once-A-Month Steroid Treatment for Patients with Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00004990 - Completed
  Glomerulonephritis; Nephrotic Syndrome
  
• Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children
  ClinicalTrials.gov Identifier: NCT00129688 - Completed
  Neutropenia; Cancer; Fever
  
• Once-Daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
  ClinicalTrials.gov Identifier: NCT00532168 - Recruiting
  HIV Infections
  
• Once-Daily Drug Regimen for HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001968 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infections
  
• Once-Daily HAART Regimen Administration in HIV-1 Infected Children in Burkina Faso
  ClinicalTrials.gov Identifier: NCT00122538 - Active, not recruiting
  HIV Infection; AIDS
  
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
  ClinicalTrials.gov Identifier: NCT00289198 - Completed
  Perennial Allergic Rhinitis
  
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
  ClinicalTrials.gov Identifier: NCT00197262 - Active, not recruiting
  Rhinitis
  
• Once-Daily Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis. The Einstein-DVT Dose-Finding Study
  ClinicalTrials.gov Identifier: NCT00395772 - Completed
  Treatment of Venous Thromboembolism
  
• Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
  ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
  HIV Infections
  
• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
  ClinicalTrials.gov Identifier: NCT00003034 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• OncoVEX GM-CSF in Patients With Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00402025 - Recruiting
  Pancreatic Cancer
  
• Ondansetron for the Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00033085 - Active, not recruiting
  Cocaine-Related Disorders; Drug Administration Schedule
  
• Ondansetron for the Treatment of Methamphetamine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00040053 - Active, not recruiting
  Amphetamine-Related Disorders
  
• Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00006348 - Active, not recruiting
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Ondansetron Reduce Vomiting Associated With Ketamine PSA
  ClinicalTrials.gov Identifier: NCT00387556 - Completed
  Conscious Sedation
  
• Ondansetron Treatment for Alcoholism
  ClinicalTrials.gov Identifier: NCT00000443 - Completed
  Alcoholism
  
• Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
  ClinicalTrials.gov Identifier: NCT00016380 - Active, not recruiting
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; nausea and vomiting; Quality of Life
  
• One Hour Preoperative Gatifloxacin
  ClinicalTrials.gov Identifier: NCT00350363 - Recruiting
  Ophthalmic Surgery
  
• One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
  ClinicalTrials.gov Identifier: NCT00142337 - Active, not recruiting
  HIV; Postpartum Period
  
• One Tablet Sublingual Immunotherapy in Adults with Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00146991 - Terminated
  Seasonal Allergic Rhinoconjunctivitis
  
• One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00358397 - Recruiting
  Tumors
  
• One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
  ClinicalTrials.gov Identifier: NCT00465855 - Recruiting
  Carbon Monoxide Poisoning
  
• One Week PTHrP IV Dose Escalation Study
  ClinicalTrials.gov Identifier: NCT00580788 - Not yet recruiting
  Osteoporosis; Humoral Hypercalcemia of Malignancy; Hyperparathyroidism
  
• One Year Drug Treatment in First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00159081 - Active, not recruiting
  Schizophrenia
  
• One Year Extension Study To Protocol C2/5/TZ:MS-05
  ClinicalTrials.gov Identifier: NCT00464958 - Not yet recruiting
  Spasticity; Fatigue
  
• One Year Glargine Treatment in CFRD Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00483769 - Completed
  Cystic Fibrosis; Glucose Metabolism Disorders
  
• One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00409851 - Completed
  Hypertension
  
• One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)
  ClinicalTrials.gov Identifier: NCT00246467 - Active, not recruiting
  Plague
  
• One-Lung Ventilation: Expression of Pulmonary Inflammatory Mediators
  ClinicalTrials.gov Identifier: NCT00515905 - Recruiting
  Thoracic Surgery With One-Lung Ventilation
  
• One-Year Prospective Observational Study of BMI Change Effect of 5-Alpha Reductase Inhibitor in Korean BPH Patients
  ClinicalTrials.gov Identifier: NCT00472251 - Recruiting
  Benign Prostatic Hyperplasia
  
• Onercept in the Treatment and Re-Treatment of Subjects with Moderate to Severe Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00090129 - Terminated
  Psoriatic Arthritis
  
• Online Caregiver Psychoeducation and Support for Alzheimer's
  ClinicalTrials.gov Identifier: NCT00416078 - Recruiting
  Alzheimer's Disease
  
• Online Family Support and Education for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00046085 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Online HIV Prevention Vignette Evaluation
  ClinicalTrials.gov Identifier: NCT00249327 - Completed
  HIV Infections
  
• Online Survey on Computer Password Usage
  ClinicalTrials.gov Identifier: NCT00357136 - Recruiting
  Carpal Tunnel Syndrome
  
• ONO-7436 Phase II Study in Japan
  ClinicalTrials.gov Identifier: NCT00212602 - Completed
  Malignant Tumor
  
• Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's
  ClinicalTrials.gov Identifier: NCT00363727 - Active, not recruiting
  Parkinson's Disease; Dyskinesias
  
• Onsite versus Referral Models of Primary Care for Substance Abusing Patients
  ClinicalTrials.gov Identifier: NCT00057096 - Completed
  Substance Abuse
  
• OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
  ClinicalTrials.gov Identifier: NCT00439127 - Completed
  Differentiated Thyroid Carcinoma
  
• Ontak (Denileukin Diftitox) in Patients With SM
  ClinicalTrials.gov Identifier: NCT00493129 - Completed
  Leukemia; Systemic Mastocytosis
  
• ONTAK to Estimate Response in Cutaneous T-Cell Lymphoma According to CD25 Status
  ClinicalTrials.gov Identifier: NCT00279396 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
  ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
  Cardiovascular Diseases
  
• Ontario ICU Clinical Best Practices Demonstration Project
  ClinicalTrials.gov Identifier: NCT00332982 - Completed
  Ventilator Acquired Pneumonia; Catheter Related Blood Stream Infections; Pressure Ulcer Prophylaxis; DVT Prophylaxis; Restrictive Blood Transfusion Strategy; Daily Spontaeous Breathing Trials
  
• Ontario MDCT Coronary Angiography Study (OMCAS)
  ClinicalTrials.gov Identifier: NCT00371891 - Recruiting
  Coronary Arteriosclerosis; Cardiomyopathies; Heart Defects, Congenital; Heart Valve Diseases
  
• Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients
  ClinicalTrials.gov Identifier: NCT00525187 - Completed
  Prevalence of Onychomycosis; Diabetic Neuropathic Patients; Diagnostic of Onychomycosis; Patients Clinically Suspected of Onychomycosis; Reliability of the Diagnosis of Onychomycosis
  
• ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006106 - Recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• OPAL - Insulin Glulisine, Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00272012 - Completed
  Diabetes Mellitus Type 2
  
• OPALS Cardiac Arrest Database (OCAD)
  ClinicalTrials.gov Identifier: NCT00300703 - Recruiting
  Cardiac Arrest
  
• OPALS Critical Care Sub-Studies
  ClinicalTrials.gov Identifier: NCT00212953 - Active, not recruiting
  Cardiac Arrest
  
• OPALS Pediatric Study
  ClinicalTrials.gov Identifier: NCT00298532 - Active, not recruiting
  Seizure
  
• Open Label Arimidex in Gynecomastia
  ClinicalTrials.gov Identifier: NCT00241436 - Completed
  Gynecomastia
  
• Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00432653 - Not yet recruiting
  Ankylosing Spondylitis
  
• Open Label Comparative Study on Celecoxib Efficacy and Safety vs Non-Selective NSAID in Acute Pain Due to Ankle Sprain
  ClinicalTrials.gov Identifier: NCT00446797 - Recruiting
  Sprains and Strains
  
• Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities
  ClinicalTrials.gov Identifier: NCT00311649 - Active, not recruiting
  Influenza
  
• Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
  ClinicalTrials.gov Identifier: NCT00148330 - Active, not recruiting
  Diabetic macular oedema
  
• Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00477594 - Recruiting
  Familial Hypercholesterolemia
  
• Open Label Extension Study Evaluating Sildenafil Citrate When Used In Combination with Epoprostenol In PAH
  ClinicalTrials.gov Identifier: NCT00147641 - Active, not recruiting
  Pulmonary Hypertension
  
• Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00440037 - Recruiting
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  ClinicalTrials.gov Identifier: NCT00116688 - Recruiting
  Thrombocytopenia
  
• Open Label Extension Study of Bifeprunox
  ClinicalTrials.gov Identifier: NCT00366171 - Completed
  Schizophrenia
  
• Open Label Extension Study of Eculizumab in Patients with Transfusion Dependent PNH.
  ClinicalTrials.gov Identifier: NCT00122317 - Active, not recruiting
  Transfusion dependent, hemolytic paroxysmal nocturnal hemoglobinuria.
  
• Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00139594 - Completed
  Bipolar Disorder
  
• Open Label Extension Study to Evaluate the Long Term Use of Valsartan in 1-5 Year Old Hypertensive Children
  ClinicalTrials.gov Identifier: NCT00457626 - Recruiting
  Hypertension
  
• Open Label Extension Trial for Rotigotine in Advanced Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00501969 - Active, not recruiting
  Advanced Parkinson's Disease
  
• Open Label Follow up Trial of Rotigotine in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00505687 - Active, not recruiting
  Parkinson's Disease
  
• Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
  ClinicalTrials.gov Identifier: NCT00002025 - Completed
  Cytomegalovirus Infections; Cytomegalovirus Retinitis; HIV Infections
  
• Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00260793 - Recruiting
  Parkinson's Disease
  
• Open Label INCB018424 in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
  ClinicalTrials.gov Identifier: NCT00509899 - Recruiting
  Myelofibrosis; Polycythemia Vera; Thrombocytosis
  
• Open Label Long Term Follow up Study With Certolizumab Pegol for Patients Completing C87042
  ClinicalTrials.gov Identifier: NCT00333788 - Recruiting
  Crohn Disease
  
• Open Label Long-Term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
  ClinicalTrials.gov Identifier: NCT00526071 - Recruiting
  Fabry Disease
  
• Open Label Long-Term Safety Study of CDP870 (Certolizumab Pegol) for Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160693 - Active, not recruiting
  Rheumatoid Arthritis
  
• Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00280956 - Completed
  Crohn's Disease
  
• Open Label Non-Comparative Clinical Trial of Tigecycline in Patients With Catheter Infection
  ClinicalTrials.gov Identifier: NCT00419991 - Recruiting
  Staphylococcal Infections
  
• Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer
  ClinicalTrials.gov Identifier: NCT00582985 - Recruiting
  Cancer; Neoplasm Metastasis
  
• Open Label Phase 3 Study of NABI-IGIV 10% [(HUMAN)] In Subjects With Primary Immune Deficiency Disorders (PIDD)
  ClinicalTrials.gov Identifier: NCT00538915 - Recruiting
  Primary Immune Deficiency Disorders; Antibody Deficiency Syndromes
  
• Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00280397 - Recruiting
  Cancer
  
• Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
  ClinicalTrials.gov Identifier: NCT00407498 - Recruiting
  Neoplasm
  
• Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00000695 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Open Label Phase III Duloxetine Study for Stress Urinary Incontinence
  ClinicalTrials.gov Identifier: NCT00191204 - Completed
  Urinary Incontinence Stress
  
• Open Label Randomized Neoadjuvant Chemotherapy (Paclitaxel Followed by FEC) Versus Paclitaxel and RAD001 Followed by FEC in Women With Triple Receptor-Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499603 - Recruiting
  Breast Cancer
  
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00160628 - Completed
  Epilepsy, Partial
  
• Open Label Safety and Efficacy Study of Levetiracetam in Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00160654 - Completed
  Epilepsy, Partial
  
• Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With HIV Neuropathy
  ClinicalTrials.gov Identifier: NCT00264875 - Recruiting
  Peripheral Neuropathy; HIV
  
• Open Label Safety Efficacy Study of Levetiracetam in Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00152373 - Completed
  Epilepsy, Partial
  
• Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients with Refractory Epilepsy.
  ClinicalTrials.gov Identifier: NCT00175864 - Not yet recruiting
  Epilepsy
  
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
  ClinicalTrials.gov Identifier: NCT00330785 - Completed
  Hypertension; Dyslipidemia
  
• Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms.
  ClinicalTrials.gov Identifier: NCT00553449 - Active, not recruiting
  Heartburn; Gastroesophageal Reflux
  
• Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00432068 - Recruiting
  Healthy
  
• Open Label Study of Adalimumab in Subjects Who Have a Sub-Optimal Response to Systemic Therapy or Phototherapy
  ClinicalTrials.gov Identifier: NCT00566722 - Not yet recruiting
  Psoriasis
  
• Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
  ClinicalTrials.gov Identifier: NCT00425230 - Recruiting
  Chronic Phantom Limb Pain
  
• Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
  Bipolar Disorder
  
• Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting
  ClinicalTrials.gov Identifier: NCT00509990 - Completed
  Atopic Dermatitis
  
• Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034658 - Completed
  Mycoses
  
• Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections
  ClinicalTrials.gov Identifier: NCT00034632 - Completed
  Mycoses
  
• Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
  ClinicalTrials.gov Identifier: NCT00237224 - Terminated
  Breast Cancer
  
• Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00454207 - Recruiting
  Pulmonary Hypertension
  
• Open Label Study of Subcutaneous Homoharringtonine in Patients With Advanced CML
  ClinicalTrials.gov Identifier: NCT00462943 - Recruiting
  Chronic Myelogenous Leukemia
  
• Open Label Study of the Safety and Contraceptive Efficacy of BufferGel® With Diaphragm
  ClinicalTrials.gov Identifier: NCT00397670 - Completed
  Contraception
  
• Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
  ClinicalTrials.gov Identifier: NCT00298818 - Active, not recruiting
  Epilepsy; Mental Retardation; Developmental Disabilities
  
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
  ClinicalTrials.gov Identifier: NCT00174304 - Completed
  Hypertension; Hyperlipidemia
  
• Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250 µg in Patients of Chinese Origin With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00370071 - Recruiting
  Multiple Sclerosis
  
• Open Label Study to Evaluate the Safety of Twice Daily Oral Carvedilol
  ClinicalTrials.gov Identifier: NCT00129363 - Active, not recruiting
  Congestive Heart Failure
  
• Open Label Study with Subjects 18-65 Years Old with Partial Onset Seizures Who Are Currently Taking Levetracetam.
  ClinicalTrials.gov Identifier: NCT00152503 - Completed
  Epilepsy, Partial
  
• Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
  ClinicalTrials.gov Identifier: NCT00462202 - Recruiting
  Diabetic Nephropathy
  
• Open label trial exploring a switch from oral medications, to risperidone depot microspheres
  ClinicalTrials.gov Identifier: NCT00034775 - Completed
  Schizophrenia
  
• Open Label Trial of Acamprosate in Bipolar Alcoholics
  ClinicalTrials.gov Identifier: NCT00330486 - Recruiting
  Alcohol Dependence; Bipolar Disorder
  
• Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
  ClinicalTrials.gov Identifier: NCT00241176 - Recruiting
  Tourette's Syndrome; Tic Disorders
  
• Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00573547 - Active, not recruiting
  Depression
  
• Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.
  ClinicalTrials.gov Identifier: NCT00255619 - Completed
  Chronic Renal Failure
  
• Open Label Trial to Study the Long-Term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy
  ClinicalTrials.gov Identifier: NCT00175851 - Not yet recruiting
  Epilepsy
  
• Open Label, 48 Week Study of the Ability of Lopinavir/Ritonavir to Influence the Immune Response in Patients Who Are on an HIV Suppressive Regimen But Have Demonstrated a Blunted Immune Recovery.
  ClinicalTrials.gov Identifier: NCT00344487 - Recruiting
  HIV
  
• Open Label, Dose Escalation Phase I Study of AZD2281
  ClinicalTrials.gov Identifier: NCT00572364 - Recruiting
  Advanced Solid Malignancies
  
• Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA
  ClinicalTrials.gov Identifier: NCT00418717 - Active, not recruiting
  Arthritis, Rheumatoid
  
• Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder.
  ClinicalTrials.gov Identifier: NCT00307684 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Open Label, Phase I ZD6474 Head and Neck Cancer Study
  ClinicalTrials.gov Identifier: NCT00450138 - Recruiting
  Head and Neck Cancer
  
• Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-Malignant, Chronic Pain
  ClinicalTrials.gov Identifier: NCT00485225 - Recruiting
  Chronic, Non Malignant Pain
  
• Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.
  ClinicalTrials.gov Identifier: NCT00244127 - Active, not recruiting
  Aggressive Non-Hodgkin's Lymphoma in the Elderly.
  
• OPEN LABEL, ZONEGRAN (ZONISAMIDE) IN PARTIAL ONSET SEIZURES
  ClinicalTrials.gov Identifier: NCT00215592 - Active, not recruiting
  Epilepsy
  
• Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00554086 - Recruiting
  Prostate Cancer
  
• Open Lung Approach During General Anaesthesia to Prevent Post-Operative Pulmonary Complications
  ClinicalTrials.gov Identifier: NCT00426790 - Recruiting
  Postoperative Complications
  
• Open Study of CEP-701 in Patients with Refractory Acute Myeloid Leukemia with FLT-3 Mutation
  ClinicalTrials.gov Identifier: NCT00030186 - Completed
  Leukemia, Myeloid
  
• Open Study of Enoxaparin vs. Unfractionated Heparin in Patients with Acute Coronary Syndromes
  ClinicalTrials.gov Identifier: NCT00043784 - Completed
  Unstable Angina; Myocardial Infarction; Myocardial Ischemia
  
• Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering from Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00152412 - Completed
  Allergic Rhinitis
  
• Open Trial of Family-Based Treatment for Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00417521 - Completed
  Anorexia Nervosa
  
• Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
  ClinicalTrials.gov Identifier: NCT00213109 - Completed
  Type 1 Diabetes Mellitus
  
• Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
  ClinicalTrials.gov Identifier: NCT00334503 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Open Versus Endoscopic Surgery of Craniomaxillofacial (CMF) Condylar Neck Fractures
  ClinicalTrials.gov Identifier: NCT00206011 - Recruiting
  Condylar Neck Fractures
  
• Open Vs Laparoscopic Pyloromyotomy for Pyloric Stenosis
  ClinicalTrials.gov Identifier: NCT00144924 - Recruiting
  Pyloric Stenosis
  
• Open Wedge High Tibia Osteotomy
  ClinicalTrials.gov Identifier: NCT00206037 - Terminated
  High Tibia Osteotomy
  
• Open, Non-comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
  ClinicalTrials.gov Identifier: NCT00002010 - Completed
  Meningitis; HIV Infections
  
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
  ClinicalTrials.gov Identifier: NCT00002040 - Completed
  Meningitis, Cryptococcal; HIV Infections
  
• Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia
  ClinicalTrials.gov Identifier: NCT00292071 - Completed
  Fungal Infection
  
• Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants
  ClinicalTrials.gov Identifier: NCT00330395 - Active, not recruiting
  Candidiasis
  
• Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients
  ClinicalTrials.gov Identifier: NCT00002062 - Completed
  Cryptosporidiosis; HIV Infections
  
• Open-Label (Everyone Who Participates Receives Drug), Long-Term, Follow-Up Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
  ClinicalTrials.gov Identifier: NCT00150709 - Completed
  Epilepsy, Partial
  
• Open-Label Adalimumab for Ulcerative Colitis Patients
  ClinicalTrials.gov Identifier: NCT00421642 - Recruiting
  Ulcerative Colitis
  
• Open-label Adjunctive Zonisamide for Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00047567 - Terminated
  Bipolar Disorders
  
• Open-Label Assessment of the Efficacy & Safety of Efalizumab in the Treatment of Mod-Severe Hidradenitis Suppurativa
  ClinicalTrials.gov Identifier: NCT00134134 - Completed
  Hidradenitis Suppurativa
  
• Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder
  ClinicalTrials.gov Identifier: NCT00182013 - Completed
  Bipolar Spectrum Disorder
  
• Open-Label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-Daily Administration of Lavoltidine 40 mg.
  ClinicalTrials.gov Identifier: NCT00551473 - Completed
  Gastroesophageal Reflux Disease
  
• Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
  ClinicalTrials.gov Identifier: NCT00204503 - Active, not recruiting
  Bipolar I or II Depression and Alcohol Abuse or Dependence
  
• Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials
  ClinicalTrials.gov Identifier: NCT00191594 - Completed
  Major Depressive Disorder
  
• Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00583193 - Recruiting
  Posttraumatic Stress Disorders
  
• Open-Label Evaluation Of LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
  ClinicalTrials.gov Identifier: NCT00144872 - Completed
  Typical Absence Epilepsy
  
• Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00381238 - Recruiting
  Alzheimer's Disease
  
• Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
  ClinicalTrials.gov Identifier: NCT00097370 - Active, not recruiting
  Hypereosinophilic Syndrome; Hypereosinophilia
  
• Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00314912 - Active, not recruiting
  Alzheimer's Disease
  
• Open-Label Extension Safety Study of PROCRIT in Patients with Anemia of Chronic Disease Due to Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00123149 - Not yet recruiting
  Rheumatoid Arthritis; Anemia
  
• Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)
  ClinicalTrials.gov Identifier: NCT00391625 - Active, not recruiting
  Gaucher Disease, Type 1
  
• Open-Label Extension Study of 23mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00566501 - Not yet recruiting
  Alzheimer's Disease
  
• Open-Label Extension Study of Botulinum Type A Toxin (Dysport®) for the Treatment of Cervical Dystonia
  ClinicalTrials.gov Identifier: NCT00288509 - Active, not recruiting
  Cervical Dystonia
  
• Open-Label Extension Study of RN624
  ClinicalTrials.gov Identifier: NCT00399490 - Recruiting
  Osteoarthritis of the Knee
  
• Open-Label Extension Study of Rosiglitazone XR as Adjunctive Therapy in Subjects With Mild-to-Moderate Alzheimer's
  ClinicalTrials.gov Identifier: NCT00490568 - Recruiting
  Alzheimers Disease
  
• Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
  ClinicalTrials.gov Identifier: NCT00448539 - Recruiting
  Refractory Partial Onset Seizures
  
• Open-Label Extension Study of Safety and Tolerability of Pregabalin in Pediatric Patients With Partial-Onset Seizures
  ClinicalTrials.gov Identifier: NCT00448916 - Recruiting
  Epilepsies, Partial
  
• Open-Label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
  ClinicalTrials.gov Identifier: NCT00310375 - Recruiting
  Epilepsies, Partial
  
• Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial
  ClinicalTrials.gov Identifier: NCT00310388 - Recruiting
  Epilepsies, Partial
  
• Open-Label Extension to Protocol 1042-0500
  ClinicalTrials.gov Identifier: NCT00442104 - Recruiting
  Infantile Spasms
  
• Open-Label Extension to Protocol 1042-0600
  ClinicalTrials.gov Identifier: NCT00512317 - Recruiting
  Epilepsies, Partial
  
• Open-Label Extension Treatment With TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trial 016.0012
  ClinicalTrials.gov Identifier: NCT00356590 - Active, not recruiting
  Rheumatoid Arthritis
  
• Open-Label Extension Treatment With TNFR:Fc for Participating Patients in TNFR:Fc Clinical Trials
  ClinicalTrials.gov Identifier: NCT00357903 - Active, not recruiting
  Rheumatoid Arthritis
  
• Open-Label Natalizumab Safety Extension Study
  ClinicalTrials.gov Identifier: NCT00276172 - Completed
  Multiple Sclerosis
  
• Open-Label Pharmacokinetic Study of Brivaracetam in Children (1 Month - < 16 Years Old) With Epilepsy
  ClinicalTrials.gov Identifier: NCT00422422 - Not yet recruiting
  Epilepsy
  
• Open-Label Phase 1/2 Study of VELCADE (Bortezomib) for Injection in Patients With Light-Chain (AL)-Amyloidosis
  ClinicalTrials.gov Identifier: NCT00298766 - Recruiting
  Amyloidosis
  
• Open-Label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00242554 - Completed
  Prostate Cancer
  
• Open-Label Posterior Juxtacleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients with AMD
  ClinicalTrials.gov Identifier: NCT00065728 - Recruiting
  Macular Degeneration
  
• Open-Label Program of Dideoxycytidine ( ddC ) to be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV Disease
  ClinicalTrials.gov Identifier: NCT00002081 - Completed
  HIV Infections
  
• Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India
  ClinicalTrials.gov Identifier: NCT00486382 - Recruiting
  Visceral Leishmaniasis; Post-Kala-Azar Dermal Leishmaniasis
  
• Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00116649 - Active, not recruiting
  Keratosis
  
• Open-Label Safety/Efficacy Study of C1 Esterase Inhibitor (C1INH-nf) in the Treatment of Acute Hereditary Angioedema (HAE) Attacks
  ClinicalTrials.gov Identifier: NCT00438815 - Recruiting
  Hereditary Angioedema
  
• Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00233558 - Terminated
  Rheumatoid Arthritis
  
• Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
  ClinicalTrials.gov Identifier: NCT00524784 - Not yet recruiting
  Graft Versus Host Disease; Hematological Malignancies
  
• Open-Label Study Evaluating the Resistance Profile of Single Dose Nevirapine(NVP) When Combined with a 4 or 7 Day Course of Zidovudine(ZDV)+3TC Compared to Single Dose Nevirapine for the Prevention of Mother to Child Transmission (pMTCT) of HIV - Treatmen
  ClinicalTrials.gov Identifier: NCT00144183 - Completed
  Acquired Immunodeficiency Syndrome
  
• Open-Label Study of ARD-0403 in Testosterone Deficient Men
  ClinicalTrials.gov Identifier: NCT00448955 - Recruiting
  Hypogonadism
  
• Open-Label Study of ARD-0403 in Testosterone Deficient Men
  ClinicalTrials.gov Identifier: NCT00562731 - Recruiting
  Hypogonadism
  
• Open-Label Study of CS1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00521404 - Recruiting
  Pancreatic Cancer
  
• Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00529789 - Recruiting
  Major Depressive Disorder
  
• Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients with MPS VI
  ClinicalTrials.gov Identifier: NCT00048711 - Completed
  Mucopolysaccharidosis VI
  
• Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
  Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
  
• Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression
  ClinicalTrials.gov Identifier: NCT00237666 - Recruiting
  Bipolar II Disorder; Major Depressive Episode
  
• Open-Label Study of H5 Vaccine in Participants of Protocol 04-077
  ClinicalTrials.gov Identifier: NCT00402649 - Active, not recruiting
  Influenza
  
• Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
  ClinicalTrials.gov Identifier: NCT00505934 - Not yet recruiting
  Epilepsy
  
• Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  ClinicalTrials.gov Identifier: NCT00535392 - Recruiting
  Epilepsy
  
• Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
  ClinicalTrials.gov Identifier: NCT00301405 - Terminated
  Chronic Prostatitis; Pelvic Pain
  
• Open-Label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms
  ClinicalTrials.gov Identifier: NCT00463541 - Completed
  Urinary Bladder, Overactive
  
• Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
  ClinicalTrials.gov Identifier: NCT00418262 - Recruiting
  Fetal Alcohol Syndrome; Attention Deficit Disorder (ADD); Attention Deficit Disorder With Hyperactivity (ADHD)
  
• Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine
  ClinicalTrials.gov Identifier: NCT00511095 - Active, not recruiting
  Hepatitis B
  
• Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.
  ClinicalTrials.gov Identifier: NCT00298779 - Active, not recruiting
  Tumors; Non-Hodgkins's Lymphoma
  
• Open-Label Study to Compare Sevelamer Carbonate Powder Dosed Once Per Day to Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Patients With Chronic Kidney Disease on Hemodialysis.
  ClinicalTrials.gov Identifier: NCT00268957 - Completed
  Chronic Kidney Disease; Hemodialysis; Hyperphosphatemia; Chronic Renal Insufficiency; End Stage Renal Disease
  
• Open-Label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
  ClinicalTrials.gov Identifier: NCT00189306 - Active, not recruiting
  Superficial Basal Cell Carcinoma
  
• Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
  ClinicalTrials.gov Identifier: NCT00387010 - Completed
  Pain
  
• Open-Label Study to Evaluate the Efficacy and Safety of an Extended-Cycle, Low Dose Combination Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00196326 - Active, not recruiting
  Contraception
  
• Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00362479 - Active, not recruiting
  Contraception
  
• Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure
  ClinicalTrials.gov Identifier: NCT00511407 - Completed
  Acute Renal Failure
  
• Open-Label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693
  ClinicalTrials.gov Identifier: NCT00493818 - Recruiting
  Tumors; Lymphoma
  
• Open-Label Study With Bosentan in Interstitial Lung Disease
  ClinicalTrials.gov Identifier: NCT00319033 - Completed
  Interstitial Lung Disease; Scleroderma
  
• Open-Label Study with Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) with Partial Onset Seizures.
  ClinicalTrials.gov Identifier: NCT00152451 - Completed
  Epilepsy, Partial
  
• Open-Label Treatment Extension Study for Patients Who Complete Study RNA200103-201
  ClinicalTrials.gov Identifier: NCT00230490 - Active, not recruiting
  Hepatitis B, Chronic
  
• Open-Label Treatment with Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients with Major Depression
  ClinicalTrials.gov Identifier: NCT00042562 - Completed
  Major Depressive Disorder
  
• Open-Label Treatment With MPC-7869 for Patients With Alzheimer's  Who Previously Participated in an MPC-7869 Protocol
  ClinicalTrials.gov Identifier: NCT00380276 - Recruiting
  Alzheimer's Disease 
  
• Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00191880 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Open-Label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00293124 - Active, not recruiting
  Gastrointestinal Stromal Tumors
  
• Open-Label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
  ClinicalTrials.gov Identifier: NCT00171938 - Active, not recruiting
  Glioblastoma
  
• Open-Label Trial of LEUKINE® in Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00206700 - Completed
  Crohn Disease
  
• Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors
  ClinicalTrials.gov Identifier: NCT00115128 - Active, not recruiting
  Healthy
  
• Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
  ClinicalTrials.gov Identifier: NCT00267943 - Completed
  Hypertension
  
• Open-Label Trial of the Use of Minocycline in the Treatment of Asthma
  ClinicalTrials.gov Identifier: NCT00536042 - Active, not recruiting
  Asthma
  
• Open-label Trial on the Effect of I.V. Zometa 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients with Bone Metastasis
  ClinicalTrials.gov Identifier: NCT00035997 - Active, not recruiting
  Prostate Cancer
  
• Open-Label Ziprasidone Study for Psychosis Treatment in Adolescents
  ClinicalTrials.gov Identifier: NCT00421954 - Recruiting
  Schizophreniform Disorder; Schizoaffective Disorder; Psychosis; Depressive Disorder, Major; Bipolar Disorder
  
• Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed ACH443-014A
  ClinicalTrials.gov Identifier: NCT00380159 - Recruiting
  HIV-1 Infection
  
• Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524
  ClinicalTrials.gov Identifier: NCT00192478 - Completed
  Respiratory Syncytial Virus Infections
  
• Open-Label, Follow-on Trial to Assess the Long-Term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.
  ClinicalTrials.gov Identifier: NCT00546351 - Active, not recruiting
  Painful Diabetic Neuropathy
  
• Open-Label, Long-Term Balsalziade Disodium Tablet Ulcerative Colitis Study
  ClinicalTrials.gov Identifier: NCT00486031 - Active, not recruiting
  Inflammatory Bowel Disease; Ulcerative Colitis
  
• Open-Label, Long-Term, Safety and Tolerability Study of Intravitreal VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00527423 - Not yet recruiting
  Macular Degeneration
  
• Open-Label, Multiple-Dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00240747 - Terminated
  Gram-Positive Bacterial Infections
  
• Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab
  ClinicalTrials.gov Identifier: NCT00259740 - Active, not recruiting
  Relapsed or Plateau-Phase Multiple Myeloma
  
• Open-Label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
  ClinicalTrials.gov Identifier: NCT00317538 - Completed
  Rheumatoid Arthritis
  
• Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD
  ClinicalTrials.gov Identifier: NCT00509548 - Recruiting
  Macular Degeneration; Choroidal Neovascularization
  
• Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Diaologues Time to Talk Program
  ClinicalTrials.gov Identifier: NCT00401726 - Completed
  Depressive Disorder, Major
  
• Open-Label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00504062 - Completed
  Asthma
  
• Open-Label, Uncontrolled, Single Center, Phase II Trial to Describe the Safety and Immunogenicity of Fluzone®
  ClinicalTrials.gov Identifier: NCT00524940 - Completed
  Influenza
  
• Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00376129 - Completed
  Atopic Dermatitis
  
• Open-Labeled, Randomized Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE.
  ClinicalTrials.gov Identifier: NCT00063791 - Terminated
  Multiple Myeloma
  
• OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
  ClinicalTrials.gov Identifier: NCT00180375 - Completed
  Ventricular Tachycardia; Ventricular Fibrillation
  
• Operating Room Outcomes After Resident Training on a Virtual Reality Simulator
  ClinicalTrials.gov Identifier: NCT00459472 - Active, not recruiting
  Gall Bladder Disease
  
• Operations Research to Improve Newborn Health
  ClinicalTrials.gov Identifier: NCT00198887 - Completed
  Pregnancy Complications
  
• Operative or Conservative Treatment for Subacromial Impingment Syndrome?
  ClinicalTrials.gov Identifier: NCT00428870 - Recruiting
  Subacromial Impingement Syndrome
  
• Operative Treatment of Extraarticular Colles' Fractures of the Distal Radius (OTEC)
  ClinicalTrials.gov Identifier: NCT00271726 - Recruiting
  Colles' Fracture; Radius Fractures
  
• Operative Versus Conservative Treatment of Scaphoid Fractures
  ClinicalTrials.gov Identifier: NCT00205985 - Completed
  Scaphoid Fracture
  
• Operative Versus Non Operative Treatment for Unstable Ankle Fractures
  ClinicalTrials.gov Identifier: NCT00336752 - Recruiting
  Ankle Injuries
  
• Operative Versus Non-Operative Treatment of Achilles Tendon Rupture
  ClinicalTrials.gov Identifier: NCT00284648 - Active, not recruiting
  Achilles Tendon Rupture
  
• Ophtec Iris Reconstruction Lens Implant Model 311 for the Treatment of Visual Disturbances
  ClinicalTrials.gov Identifier: NCT00201604 - Recruiting
  Photophobia; Visual Disturbances
  
• Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
  ClinicalTrials.gov Identifier: NCT00238914 - Active, not recruiting
  Behavior Therapy; Naltrexone; Opioid Dependence
  
• Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
  ClinicalTrials.gov Identifier: NCT00246532 - Recruiting
  Chronic Low Back Pain; Opioid-Induced Hyperalgesia
  
• Opioid Agonist and Antagonist Effects - 6
  ClinicalTrials.gov Identifier: NCT00142727 - Terminated
  
  
• Opioid and Cannabinoid Pharmacokinetic Interactions
  ClinicalTrials.gov Identifier: NCT00308555 - Recruiting
  Pain; Neoplasms
  
• Opioid Compromise in Hypertension--Modulating Factors
  ClinicalTrials.gov Identifier: NCT00005434 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109941 - Completed
  recurrent pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Opioid Maintenance Medications Comparison Study
  ClinicalTrials.gov Identifier: NCT00344812 - Completed
  Opioid Dependence
  
• Opioid Receptors Influence Ischemia-Reperfusion Injury
  ClinicalTrials.gov Identifier: NCT00184938 - Recruiting
  Ischemia-Reperfusion Injury
  
• Opioid Rotation From Morphine to Methadone in Treatment of Non-Malignant Pain
  ClinicalTrials.gov Identifier: NCT00356083 - Completed
  Non-Malignant Chronic Pain
  
• Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain
  ClinicalTrials.gov Identifier: NCT00478101 - Completed
  Advanced Solid Cancers; Pain
  
• Opioid Withdrawal Suppression with Tramadol - 1
  ClinicalTrials.gov Identifier: NCT00142896 - Active, not recruiting
  Opioid Dependence
  
• Opioid-Potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery
  ClinicalTrials.gov Identifier: NCT00538421 - Not yet recruiting
  Aortic Diseases; Abdominal; Aneurysm; Surgery
  
• OPPOSITE: Open-label, Pilot Protocol of Patients with Rheumatoid Arthritis who Switch to Infliximab after an Incomplete Response To Etanercept
  ClinicalTrials.gov Identifier: NCT00094471 - Completed
  Rheumatoid Arthritis
  
• OPRM1 A118G SNP, Alcohol Response, and Striatal Dopamine
  ClinicalTrials.gov Identifier: NCT00401999 - Recruiting
  Alcoholism
  
• OPT-80 in Clostridium defficile-Associated Diarrhea (CDAD)
  ClinicalTrials.gov Identifier: NCT00097422 - Completed
  Diarrhea
  
• OPTAMISE: Open-Label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoporosis Influences the Clinical Effectiveness of Teriparatide
  ClinicalTrials.gov Identifier: NCT00130403 - Completed
  Osteoporosis, Postmenopausal
  
• Optic Nerve Compliance Study
  ClinicalTrials.gov Identifier: NCT00328835 - Completed
  Glaucoma
  
• Optic Nerve Sheath Fenestration
  ClinicalTrials.gov Identifier: NCT00337961 - Active, not recruiting
  Optic Nerve Sheath Fenestration
  
• Optic Neuritis Treatment Trial (ONTT)
  ClinicalTrials.gov Identifier: NCT00000146 - Active, not recruiting
  Multiple Sclerosis; Optic Neuritis
  
• Optical Biopsy of Human Skin in Conjunction With Laser Treatment
  ClinicalTrials.gov Identifier: NCT00540566 - Enrolling by invitation
  Malignant Melanoma,; Merkel Cell Carcinoma,; Basal Cell Carcinoma,; Squamous Cell Carcinoma; Atypical Nevi,; Congenital Nevi; Seborrheic Keratosis,; Paget's Disease; Dermatofibroma,; Kaposi's Sarcoma; Hypervascular Congenital Malformations; Port Wine Stain; Hemangioma; Tattoos; Scleroderma; Burns; Normal Skin
  
• Optical Clearing of the Skin in Conjunction With Laser Treatments
  ClinicalTrials.gov Identifier: NCT00580736 - Enrolling by invitation
  Port Wine Stain; Benign Vascular Lesion; Nevus of Ota; Tattoos; Scars; Acne; Hypertrichosis; Sebaceous Hyperplasia
  
• Optical Coherence Tomography (OCT) Imaging of Post Coil Aneurysm Healing.
  ClinicalTrials.gov Identifier: NCT00556309 - Enrolling by invitation
  Aneurysm
  
• Optical Coherence Tomography Comparative Study
  ClinicalTrials.gov Identifier: NCT00069199 - Completed
  Retinal Disease; Healthy
  
• Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.
  ClinicalTrials.gov Identifier: NCT00347451 - Recruiting
  Myopia; Maculopathy; Glaucoma
  
• Optical Coherence Tomography Measurements in Eyes With Band Atrophy
  ClinicalTrials.gov Identifier: NCT00395122 - Completed
  Vision Disorders
  
• Optical Coherence Tomography of Airway and Pleural Disorders
  ClinicalTrials.gov Identifier: NCT00580892 - Enrolling by invitation
  Endobronchial Disorder
  
• Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
  ClinicalTrials.gov Identifier: NCT00346372 - Recruiting
  Ocular Melanoma
  
• Optical Coherence Tomography of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00579748 - Active, not recruiting
  Barrett's Esophagus With or Without Dysplasia; Patients With Early Esophageal or Gastric Cancer; Patients With Intestinal Metaplasia of the Stomach
  
• Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers
  ClinicalTrials.gov Identifier: NCT00432471 - Recruiting
  Skin Cancer
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• Optical Spectroscopic Technique to Monitor Breast Tissue Composition in Women With Genetic Risk Factors
  ClinicalTrials.gov Identifier: NCT00500383 - Not yet recruiting
  Breast Cancer
  
• Optical Stimulation Rhizotomy Study
  ClinicalTrials.gov Identifier: NCT00575536 - Recruiting
  Spasticity
  
• Optimal Catheter Placement During Sonohysterography: Comparison of Cervical to Uterine Placement
  ClinicalTrials.gov Identifier: NCT00534963 - Completed
  Catheter Placement and Perceived Pain.
  
• Optimal Dietary Fat Pattern to Prevent Cardiovascular Disease Among Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00467168 - Completed
  Type 2 Diabetes Mellitus
  
• Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria
  ClinicalTrials.gov Identifier: NCT00320879 - Completed
  Type 2 Diabetes; Microalbuminuria
  
• Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers
  ClinicalTrials.gov Identifier: NCT00519519 - Recruiting
  Bleeding Peptic Ulcers Disease
  
• Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents
  ClinicalTrials.gov Identifier: NCT00330343 - Recruiting
  Pain; Nausea; Pruritus
  
• Optimal Duration of Olanzapine Add-on Therapy in Major Depression
  ClinicalTrials.gov Identifier: NCT00568672 - Recruiting
  Relapse Rate of a Major Depressive Episode; Safety of Olanzapine in Subjects With Major Depression
  
• Optimal Duration of Pre-Operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
  ClinicalTrials.gov Identifier: NCT00535418 - Completed
  Breast Cancer
  
• Optimal Exercise Regimens for Persons at Increased Risk
  ClinicalTrials.gov Identifier: NCT00000523 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Optimal Fluid Resuscitation
  ClinicalTrials.gov Identifier: NCT00527098 - Not yet recruiting
  Trauma
  
• Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
  ClinicalTrials.gov Identifier: NCT00191997 - Completed
  Bipolar Disorder
  
• Optimal Loading Dose of SR25990C in Patients Planned for Percutaneous Coronary Intervention
  ClinicalTrials.gov Identifier: NCT00335452 - Recruiting
  Acute Coronary Disease; Angina Unstable
  
• Optimal Management of Women With Wrist Fractures
  ClinicalTrials.gov Identifier: NCT00226031 - Active, not recruiting
  Osteoporosis; Osteopenia
  
• Optimal Multimodal Analgesia in Abdominal Hysterectomy
  ClinicalTrials.gov Identifier: NCT00209872 - Not yet recruiting
  Planned abdominal hysterectomy
  
• Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
  ClinicalTrials.gov Identifier: NCT00209885 - Not yet recruiting
  Cholecystolithiasis
  
• Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
  ClinicalTrials.gov Identifier: NCT00257959 - Completed
  Ventricular Tachycardia
  
• Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Cardiac Resynchronization Therapy
  ClinicalTrials.gov Identifier: NCT00489177 - Recruiting
  Heart Failure
  
• Optimal Timing for Repair of Left to Right Shunt Lesions
  ClinicalTrials.gov Identifier: NCT00229827 - Active, not recruiting
  Ventricular Septal Defects; Persistent Common Atrioventricular Canal
  
• Optimal Timing for Repair of Right-to-Left Shunt Lesions
  ClinicalTrials.gov Identifier: NCT00268099 - Terminated
  Congenital Disorders
  
• Optimal Treatment for Kidney Disease in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00089518 - Suspended
  HIV Infections; Kidney Disease
  
• Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck
  ClinicalTrials.gov Identifier: NCT00368407 - Completed
  Vitiligo
  
• Optimal Treatment Strategies for Sexually Abused Children
  ClinicalTrials.gov Identifier: NCT00073684 - Recruiting
  Child Abuse, Sexual; Stress Disorders, Post-Traumatic
  
• Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
  ClinicalTrials.gov Identifier: NCT00528385 - Completed
  Chronic Kidney Disease; Proteinuria
  
• Optimalization of Nephroprotection Using Atorvastatin (Sortis)
  ClinicalTrials.gov Identifier: NCT00572312 - Completed
  Chronic Kidney Disease; Proteinuria
  
• Optimalization of Nephroprotection Using N-Acetylcysteine
  ClinicalTrials.gov Identifier: NCT00572663 - Completed
  Chronic Kidney Disease; Proteinuria
  
• Optimisation and Performance of Reduced Preparation CT Colography
  ClinicalTrials.gov Identifier: NCT00212433 - Completed
  Patients With Potential Colorectal Neoplasia
  
• Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption
  ClinicalTrials.gov Identifier: NCT00120042 - Recruiting
  Placenta, Retained; Postpartum Hemorrhage
  
• Optimised Recovery With Accelerated Nutrition and GI Enhancement
  ClinicalTrials.gov Identifier: NCT00538954 - Recruiting
  Colorectal Liver Metastases
  
• Optimization of Acute Treatment in First Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00157378 - Active, not recruiting
  Schizophrenia, first-episode
  
• Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)
  ClinicalTrials.gov Identifier: NCT00421018 - Recruiting
  Allergic Asthma
  
• Optimization of Cardiac-MR Protocols
  ClinicalTrials.gov Identifier: NCT00557869 - Recruiting
  Sequence Optimization; Protocol Optimization; Normal Values; Feasibility
  
• Optimization of Drug Treatment in Hospitalized Elderly (OMAGE)
  ClinicalTrials.gov Identifier: NCT00450034 - Not yet recruiting
  Global Medical Assessment of Elderly Frail Patients
  
• Optimization of Selenoprotein P in Chinese Subjects
  ClinicalTrials.gov Identifier: NCT00428649 - Recruiting
  Selenium Deficiency
  
• Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
  ClinicalTrials.gov Identifier: NCT00314535 - Recruiting
  Healthy
  
• Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe
  ClinicalTrials.gov Identifier: NCT00314522 - Completed
  Healthy
  
• Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age
  ClinicalTrials.gov Identifier: NCT00249821 - Active, not recruiting
  Small for Gestational Age
  
• Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
  ClinicalTrials.gov Identifier: NCT00188149 - Recruiting
  Hodgkin Disease
  
• Optimization of UV Radiation Therapy in Psoriasis
  ClinicalTrials.gov Identifier: NCT00470392 - Not yet recruiting
  Psoriasis
  
• Optimize RV Selective Site Pacing Clinical Trial
  ClinicalTrials.gov Identifier: NCT00422669 - Recruiting
  Cardiac Pacing, Artificial; Cardiac Pacemaker, Artificial
  
• Optimized Intensity Modulated Irradiation for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00580983 - Enrolling by invitation
  Head and Neck Cancer
  
• Optimizing Antibiotic Use in Long Term Care
  ClinicalTrials.gov Identifier: NCT00243360 - Completed
  Urinary Tract Infection, Antibiotic Use
  
• Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00207948 - Recruiting
  HIV Infections
  
• OPTIMIZING ASSISTED COMMUNICATION DEVICES FOR CHILDREN WITH MOTOR IMPAIRMENTS USING A MODEL OF INFORMATION RATE AND CHANNEL CAPACITY
  ClinicalTrials.gov Identifier: NCT00352326 - Completed
  Cerebral Palsy
  
• Optimizing Body Composition for Function in Older Adults
  ClinicalTrials.gov Identifier: NCT00315146 - Completed
  Obesity; Overweight With Indications for Weight Loss
  
• Optimizing Cardiac Resynchronization
  ClinicalTrials.gov Identifier: NCT00205192 - Recruiting
  Heart Failure
  
• Optimizing Electroconvulsive Therapy for Depression
  ClinicalTrials.gov Identifier: NCT00045916 - Active, not recruiting
  Depression; Depressive Disorder; Bipolar Disorder
  
• Optimizing Fibromyalgia Self-Management
  ClinicalTrials.gov Identifier: NCT00321659 - Active, not recruiting
  Fibromyalgia
  
• Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
  ClinicalTrials.gov Identifier: NCT00175435 - Recruiting
  Hepatitis B
  
• Optimizing IFN Beta - 1B Dose
  ClinicalTrials.gov Identifier: NCT00473213 - Completed
  Multiple Sclerosis
  
• Optimizing Image Quality in Obese Patients Undergoing Coronary CT Angiography
  ClinicalTrials.gov Identifier: NCT00468195 - Active, not recruiting
  Coronary Angiography; Obesity; Coronary Disease
  
• Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
  ClinicalTrials.gov Identifier: NCT00427297 - Recruiting
  HIV Infections
  
• Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
  ClinicalTrials.gov Identifier: NCT00428116 - Recruiting
  HIV Infections
  
• Optimizing Pharmacotherapy for Bipolar Alcoholics
  ClinicalTrials.gov Identifier: NCT00302133 - Terminated
  Bipolar Disorder; Alcohol Dependence
  
• Optimizing Prograf® Therapy in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00297765 - Completed
  Renal Transplantation
  
• Optimizing Propofol in Obese Patients
  ClinicalTrials.gov Identifier: NCT00270335 - Completed
  Hysterectomy
  
• Optimizing Strategies to Improve STD Partner Services
  ClinicalTrials.gov Identifier: NCT00207454 - Completed
  Chlamydia Trachomatis; Neisseria Gonorrhoeae
  
• Optimizing the Ambiance during Mealtimes in Dutch Nursing Homes
  ClinicalTrials.gov Identifier: NCT00114582 - Completed
  Malnutrition
  
• Optimizing the Effect of COPD Rehabilitation
  ClinicalTrials.gov Identifier: NCT00419289 - Not yet recruiting
  Chronic Obstructive Pulmonary Disease
  
• Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression
  ClinicalTrials.gov Identifier: NCT00093847 - Recruiting
  Depression
  
• Optimizing the Use of Morphine in Pre-Term Neonates
  ClinicalTrials.gov Identifier: NCT00494429 - Recruiting
  Critically Ill Premature Neonates
  
• Optimizing Treatment for Treatment-Experienced, HIV Infected People
  ClinicalTrials.gov Identifier: NCT00537394 - Not yet recruiting
  HIV Infections
  
• Optimizing Vitamin D Nutrition in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00327847 - Recruiting
  Vitamin D Deficiency
  
• Optimum Dose of Remifentanil for Intubation in Small Children
  ClinicalTrials.gov Identifier: NCT00474071 - Recruiting
  Endotracheal Intubation
  
• Optimum Platelet Inhibition After Coronary Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00262275 - Completed
  Ischemic Heart Disease
  
• Optivate in People With Von Willebrand Disease Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00404300 - Recruiting
  Von Willebrand Disease
  
• Optivol Diagnostic Data for Discharge in Heart Failure
  ClinicalTrials.gov Identifier: NCT00420108 - Recruiting
  Heart Failure, Congestive; Cardiac Pacemaker, Artificial
  
• OPUS Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients with Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00121602 - Completed
  Anemia; Kidney Disease
  
• OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients with Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00076089 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Oral Administration of DCI to Women With PCOS
  ClinicalTrials.gov Identifier: NCT00497653 - Active, not recruiting
  Polycystic Ovary Syndrome
  
• Oral Administration of Peptides; Absorption From Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00468884 - Completed
  Healthy
  
• Oral Allergy Syndrome (OAS): a Pilot Study to Evaluate a Clinical Questionnaire as a Diagnostic Tool
  ClinicalTrials.gov Identifier: NCT00427479 - Completed
  Rhinitis; Food Allergy
  
• Oral and Depot Naltrexone - 1
  ClinicalTrials.gov Identifier: NCT00218426 - Recruiting
  Heroin Dependence
  
• Oral Androgens in Man-3 (ORAL T 3)
  ClinicalTrials.gov Identifier: NCT00161421 - Completed
  Contraception; Hypogonadism
  
• Oral Androgens in Man-4: (Short Title: Oral T-4)
  ClinicalTrials.gov Identifier: NCT00399165 - Completed
  Contraception
  
• Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
  ClinicalTrials.gov Identifier: NCT00501150 - Completed
  Gram-Positive Bacterial Infections; Staphylococcal Infections
  
• Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
  ClinicalTrials.gov Identifier: NCT00005684 - Completed
  Venous Thrombosis; Cardiovascular Diseases; Venous Thromboembolism
  
• Oral Bacteria and Allergic Disease in Children
  ClinicalTrials.gov Identifier: NCT00438646 - Recruiting
  Asthma; Rhinitis; Eczema; Respiratory Sounds; Hypersensitivity
  
• Oral Budesonide vs. Oral Mesalazine in Active CD
  ClinicalTrials.gov Identifier: NCT00300118 - Recruiting
  Crohn's Disease
  
• Oral Calcium in Pregnant Women with Hypertension
  ClinicalTrials.gov Identifier: NCT00000543 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Pre-Eclampsia; Pregnancy Toxemias; Vascular Diseases
  
• Oral Cancer Adjuvant Therapy (OCAT) Trial
  ClinicalTrials.gov Identifier: NCT00193843 - Recruiting
  Mouth Neoplasms
  
• Oral Cancer Risk Reduction Through Treatment for Tobacco and Alcohol Use
  ClinicalTrials.gov Identifier: NCT00570804 - Recruiting
  Smoking
  
• Oral Cancer Screening Among Nursing Home Dentists in Ohio
  ClinicalTrials.gov Identifier: NCT00526851 - Recruiting
  Head and Neck Cancer
  
• Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
  ClinicalTrials.gov Identifier: NCT00078663 - Not yet recruiting
  Critical Illness
  
• Oral Carnitine for Cramps in Pregnancy
  ClinicalTrials.gov Identifier: NCT00516516 - Not yet recruiting
  Muscle Cramp
  
• Oral CCI-779 Administered in Combination with Letrozole vs. Letrozole Alone in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00083993 - Terminated
  Breast Cancer; Metastases
  
• Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00280917 - Active, not recruiting
  Rheumatoid Arthritis
  
• Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
  ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
  Rheumatoid Arthritis
  
• Oral Cleft Prevention Program
  ClinicalTrials.gov Identifier: NCT00098319 - Completed
  Cleft Lip; Cleft Palate; Congenital Defects; Pregnancy
  
• Oral Cleft Prevention Program
  ClinicalTrials.gov Identifier: NCT00397917 - Recruiting
  Cleft Lip; Cleft Palate
  
• Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00299156 - Recruiting
  Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia
  
• Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of PVR
  ClinicalTrials.gov Identifier: NCT00370760 - Recruiting
  Proliferative Vitreoretinopathy
  
• Oral Collagen for Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00000401 - Active, not recruiting
  Rheumatoid Arthritis
  
• Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
  Lymphoma
  
• Oral Contraceptive Interaction Study for GW273225
  ClinicalTrials.gov Identifier: NCT00483535 - Recruiting
  Healthy Volunteers
  
• Oral Contraceptive Pills Compared to Vaginal Rings
  ClinicalTrials.gov Identifier: NCT00357526 - Completed
  Pregnancy
  
• Oral Contraceptives in the Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00205504 - Recruiting
  Metabolic Syndrome X; Insulin Resistance; Obesity; Cardiovascular Diseases
  
• Oral Dexamethasone for the Treatment of Cervical Radiculopathy
  ClinicalTrials.gov Identifier: NCT00308594 - Terminated
  Cervical Radiculopathy
  
• Oral Dexamethasone for Treatment of Migraine
  ClinicalTrials.gov Identifier: NCT00216736 - Recruiting
  Migraine
  
• Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
  ClinicalTrials.gov Identifier: NCT00212381 - Recruiting
  Cervical Dysplasia
  
• Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Deep-Vein Thrombosis Without Symptomatic Pulmonary Embolism: Einstein-DVT Evaluation
  ClinicalTrials.gov Identifier: NCT00440193 - Recruiting
  Deep Vein Thrombosis
  
• Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
  ClinicalTrials.gov Identifier: NCT00439777 - Recruiting
  Pulmonary Embolism
  
• Oral Direct Factor Xa-Inhibitor Apixaban in Patients With Acute Symptomatic Deep-Vein Thrombosis- The Botticelli DVT Dose Finding Study
  ClinicalTrials.gov Identifier: NCT00252005 - Completed
  Deep-Vein Thrombosis
  
• Oral Disintegrating Ondansetron Tablet to Reduce Vomiting from Gastroenteritis in a Pediatric Emergency Department
  ClinicalTrials.gov Identifier: NCT00120744 - Active, not recruiting
  Gastroenteritis; Vomiting; Diarrhea; Dehydration
  
• Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
  ClinicalTrials.gov Identifier: NCT00051103 - Completed
  Metastatic breast cancer
  
• Oral Enzastaurin HCl in Patients with Relapsed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00088205 - Active, not recruiting
  Mantle-Cell Lymphoma
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Oral Fluid Screening Devices
  ClinicalTrials.gov Identifier: NCT00571207 - Not yet recruiting
  Driving Under the Influence of Drugs; On-Site Oral Fluid Screening Devices; Checklist
  
• Oral Ghrelin Agonist in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00377377 - Completed
  Healthy Subjects
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Oral Human Papillomavirus Infection in HIV-Infected Men
  ClinicalTrials.gov Identifier: NCT00421486 - Recruiting
  Papillomavirus Infections; HIV Infections
  
• Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment of Brain Metastases Resulting From Non-Small Lung Cancer
  ClinicalTrials.gov Identifier: NCT00390806 - Recruiting
  Brain Metastases From Non-Small Cell Lung Cancer
  
• Oral Immunotherapy for Childhood Egg Allergy
  ClinicalTrials.gov Identifier: NCT00461097 - Recruiting
  Hypersensitivity; Immediate Hypersensitivity; Food Hypersensitivity
  
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00419562 - Recruiting
  Diabetes Mellitus, Type 1
  
• Oral Investigational Drug Vs. Approved Intravenous Treatment In Pretreated, Advanced Non-Small Cell Lung Cancer (NSCLC).
  ClinicalTrials.gov Identifier: NCT00049998 - Completed
  Non-small cell lung cancer
  
• Oral Manifestations of Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006300 - Completed
  Aplastic Anemia
  
• Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
  ClinicalTrials.gov Identifier: NCT00004781 - Completed
  HIV Infections; Candidiasis, Oral
  
• Oral Margin Spectroscopy Detection Using Optical Spectroscopy
  ClinicalTrials.gov Identifier: NCT00439205 - Recruiting
  Oral Tumors
  
• Oral Melatonin in Critically Ill High-Risk Patients
  ClinicalTrials.gov Identifier: NCT00470821 - Recruiting
  Critically Ill Patients; Mechanically Ventilated Patients
  
• Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
  ClinicalTrials.gov Identifier: NCT00330993 - Completed
  Abortion, Induced
  
• Oral Miglustat in Adult Patients With Stable Type 1 Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00319046 - Recruiting
  Type 1 Gaucher Disease
  
• Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
  ClinicalTrials.gov Identifier: NCT00487253 - Recruiting
  Cutaneous Leishmaniasis
  
• Oral Misoprostol Before Endometrial Biopsy
  ClinicalTrials.gov Identifier: NCT00200226 - Completed
  Endometrial Biopsy
  
• Oral Misoprostol for Prevention of Postpartum Hemorrhage
  ClinicalTrials.gov Identifier: NCT00097123 - Recruiting
  Postpartum Hemorrhage; Pregnancy
  
• Oral Misoprostol versus Intravenous Oxytocin in Preventing Blood Loss after Non-scheduled Cesarean Section
  ClinicalTrials.gov Identifier: NCT00107874 - Completed
  Postpartum Hemorrhage
  
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00323219 - Recruiting
  Cellulitis
  
• Oral Mucosal Epithelial Cell Sheets in Patients Suffering From Corneal Stem Cell Insufficiency or Symblepharon.
  ClinicalTrials.gov Identifier: NCT00491959 - Not yet recruiting
  Limbal Insufficiency; Symblepharon
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00285272 - Recruiting
  Chemotherapy Induced Nausea and Vomiting; Non-Hodgkins Lymphoma; Multiple Myeloma
  
• Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
  ClinicalTrials.gov Identifier: NCT00001596 - Recruiting
  Albinism; Inborn Errors of Metabolism; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Pulmonary Fibrosis
  
• Oral Prednisolone Dosing in Children Hospitalized With Asthma
  ClinicalTrials.gov Identifier: NCT00257933 - Completed
  Asthma
  
• Oral Rehydration SolutionContaining Amylase Resistant Starch in Severely Malnourished Children.
  ClinicalTrials.gov Identifier: NCT00324285 - Completed
  Diarrhoea; Severe Malnutrition
  
• Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00091559 - Completed
  Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
  
• Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00328224 - Completed
  Attention Deficit Disorder With Hyperactivity; Dental Caries; Dental Occlusion, Traumatic
  
• Oral Study Drug in Patients with Advanced Metastatic Breast Cancer who have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine
  ClinicalTrials.gov Identifier: NCT00072852 - Completed
  Breast Cancer; Neoplasm Metastasis
  
• Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00301418 - Recruiting
  Glioblastoma Multiforme; Anaplastic Astrocytoma
  
• Oral Taxane in Combination with Pemetrexed (Alimta) in Patients with Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103831 - Completed
  Non-small cell lung cancer
  
• Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects with Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00095732 - Completed
  Cystic Fibrosis; Pancreatic Insufficiency
  
• Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00279266 - Suspended
  Peripheral Neuropathy; Diabetes Mellitus; Diabetes Complications
  
• Oral Tolerance in Cow’s Milk Allergy in the Infant
  ClinicalTrials.gov Identifier: NCT00298376 - Recruiting
  Cow’s Milk Allergy
  
• Oral Tolvaptan in Patients with Hyponatremia
  ClinicalTrials.gov Identifier: NCT00072683 - Completed
  Hyponatremia
  
• Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00382733 - Recruiting
  Tumors
  
• Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193245 - Active, not recruiting
  Lung Cancer
  
• Oral Type I Collagen for Relieving Scleroderma
  ClinicalTrials.gov Identifier: NCT00005675 - Active, not recruiting
  Scleroderma; Connective Tissue Diseases
  
• Oral Tyrosine Kinase Inhibitor of VEGFR-2 to Treat Recurrent or Persistent Small-volume Epithelial Ovarian Cancer, Primary Peritoneal Serous Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00074867 - Completed
  Ovarian Cancer
  
• Oral Valganciclovir Versus Valacyclovir
  ClinicalTrials.gov Identifier: NCT00562770 - Completed
  Chronic Lymphocytic Leukemia; Leukemia
  
• Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00330551 - Recruiting
  Schizophrenia
  
• Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity
  ClinicalTrials.gov Identifier: NCT00439972 - Recruiting
  Contraception
  
• Oral Versus Vaginal Misoprostol for Induction of Labor
  ClinicalTrials.gov Identifier: NCT00148473 - Completed
  Termed pregnancy with indications for labor induction.
  
• Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.
  ClinicalTrials.gov Identifier: NCT00295672 - Completed
  Lung Neoplasm
  
• Oral Vitamin B12 as Potential Treatment of Recurrent Aphthous Stomatitis
  ClinicalTrials.gov Identifier: NCT00288769 - Active, not recruiting
  Recurrent Aphthous Stomatitis
  
• Oral Vitamin B12 Supplementation and Cognitive Performance in Elderly People
  ClinicalTrials.gov Identifier: NCT00111267 - Completed
  Cognitive decline; Cognitive Symptoms
  
• Oral Vitamin D Supplementation in Elderly Women
  ClinicalTrials.gov Identifier: NCT00575835 - Completed
  Optimal Vitamin D Administration
  
• Oral Vitamin K for Warfarin Associated Coagulopathy
  ClinicalTrials.gov Identifier: NCT00143715 - Active, not recruiting
  ...
  
• Oral Vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT
  ClinicalTrials.gov Identifier: NCT00161330 - Terminated
  Urinary Tract Infections
  
• Oral Vs Rectal Admin of Naproxen for Post-Vag Perineal Pain Control
  ClinicalTrials.gov Identifier: NCT00222976 - Completed
  post-vaginal delivery perineal pain
  
• Oral Water Ingestion in Heart Transplant Patients
  ClinicalTrials.gov Identifier: NCT00581321 - Recruiting
  Blood Pressure; Cardiac Transplantation
  
• Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00076388 - Completed
  Non-Small-Cell Lung Carcinoma
  
• Oral Zinc Therapy for the Prevention of Mucositis
  ClinicalTrials.gov Identifier: NCT00449592 - Recruiting
  Mucositis
  
• ORALIA Trial Medical Treatment vs Anoperineal Physiotherapy for Adult Anal Incontinence.
  ClinicalTrials.gov Identifier: NCT00387439 - Recruiting
  Anal Incontinence
  
• OraTest in Combination With Visual Examination and Visual Examination Alone
  ClinicalTrials.gov Identifier: NCT00537199 - Active, not recruiting
  Head and Neck Cancer; Oropharynx Cancer
  
• Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00113256 - Recruiting
  Pancreatic Cancer
  
• OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
  ClinicalTrials.gov Identifier: NCT00105937 - Completed
  Pain; Cancer
  
• ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals
  ClinicalTrials.gov Identifier: NCT00396240 - Completed
  Primary Hypercholesterolaemia
  
• Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
  ClinicalTrials.gov Identifier: NCT00010881 - Completed
  Neurological Disorders
  
• Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
  ClinicalTrials.gov Identifier: NCT00551265 - Suspended
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Orexigenic Therapy With Delta-9-Tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00316563 - Recruiting
  Cancer; Anorexia; Taste Disorders; Olfactory Disorders
  
• Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00425815 - Terminated
  Schizophrenia
  
• Org 25969 After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia
  ClinicalTrials.gov Identifier: NCT00559468 - Completed
  Anesthesia, General
  
• Organ Preservation Media Investigation
  ClinicalTrials.gov Identifier: NCT00225472 - Recruiting
  Kidney Transplant
  
• Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA
  ClinicalTrials.gov Identifier: NCT00534729 - Active, not recruiting
  Laryngeal Neoplasms; Hypopharyngeal Neoplasms
  
• Organ Protection for CABG: Propofol Versus Desflurane
  ClinicalTrials.gov Identifier: NCT00400790 - Recruiting
  Coronary Artery Bypass; Delirium, Dementia, Amnestic, Cognitive Disorders; Morbidity
  
• Organ Protection With Sevoflurane Postconditioning
  ClinicalTrials.gov Identifier: NCT00518908 - Recruiting
  Inflammation Mediators
  
• Organ Transplant Infection Prevention and Detection Project
  ClinicalTrials.gov Identifier: NCT00177801 - Recruiting
  Post Lung Transplantation
  
• Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy Project
  ClinicalTrials.gov Identifier: NCT00116272 - Recruiting
  Pregnancy
  
• Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00381407 - Recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
  ClinicalTrials.gov Identifier: NCT00344513 - Completed
  Heart Failure
  
• Organized Self-Management Support for Chronic Depression
  ClinicalTrials.gov Identifier: NCT00169286 - Active, not recruiting
  Depression
  
• Organochlorine Exposure in Relation to Timing of Natural Menopause
  ClinicalTrials.gov Identifier: NCT00353171 - Active, not recruiting
  Menopause; Smoking
  
• Organophosphate Pesticides and Human Reproductive Health
  ClinicalTrials.gov Identifier: NCT00046124 - Completed
  Fecundability; Spermatazoa Disorders; Menstruation Disorders; Endocrine Dysfunction
  
• ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium
  ClinicalTrials.gov Identifier: NCT00300391 - Recruiting
  Delirium
  
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
  ClinicalTrials.gov Identifier: NCT00141453 - Active, not recruiting
  Diabetic Nephropathy; type 2 diabeted mellitus; Proteinuria
  
• Origin and Course of Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00075322 - Recruiting
  Cutaneous T-Cell Lymphoma
  
• ORION - Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00252356 - Completed
  Major Depressive Disorder
  
• Orlistat (Xenical) in the Treatment of Overweight Patients with Nonalcoholic Steatohepatitis (NASH)
  ClinicalTrials.gov Identifier: NCT00160407 - Completed
  Fatty Liver; Hepatitis
  
• Orlistat Treatment of Crigler-Najjar Disease
  ClinicalTrials.gov Identifier: NCT00461799 - Completed
  Crigler-Najjar Syndrome
  
• Orofacial Development of Preterm and Low Birthweight Infants Versus Term Infants
  ClinicalTrials.gov Identifier: NCT00408746 - Recruiting
  Premature Birth; Infant, Newborn; Pregnancy
  
• Oropharyngeal Function After Radiotherapy With IMRT
  ClinicalTrials.gov Identifier: NCT00506324 - Recruiting
  Head and Neck Neoplasms
  
• Orthodontic Treatment With a Part-Time Wearing Esthetic Removable Appliance
  ClinicalTrials.gov Identifier: NCT00485602 - Not yet recruiting
  Malocclusion
  
• Orthopaedic Data Bank; Collection and Storage of Data Relating to Orthopaedic Disorders
  ClinicalTrials.gov Identifier: NCT00411060 - Recruiting
  Osteoarthritis; Osteosarcoma; Scoliosis; Cerebral Palsy
  
• Orthostatic Hypotension in Children With Acute Febrile Illness
  ClinicalTrials.gov Identifier: NCT00452712 - Recruiting
  Fever; Orthostatic Hypotension
  
• Orthostatic Hypotension in Rehabilitation Patients
  ClinicalTrials.gov Identifier: NCT00117585 - Not yet recruiting
  Hypotension
  
• Orthostatic Tolerance during FES (Functional Electrical Stimulation)-Walking in Paraplegia
  ClinicalTrials.gov Identifier: NCT00108043 - Recruiting
  Spinal Cord Injury
  
• Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment
  ClinicalTrials.gov Identifier: NCT00167557 - Active, not recruiting
  Hepatitis C
  
• Orthotopic Liver Transplantation Using a Living Donor
  ClinicalTrials.gov Identifier: NCT00152607 - Terminated
  Liver Disease; Liver Neoplasms
  
• ORTHOVISC Shoulder RCT
  ClinicalTrials.gov Identifier: NCT00436969 - Recruiting
  Glenohumeral Osteoarthritis
  
• ORWH:SCOR - Sex/Gender Factors Affecting Women's Health
  ClinicalTrials.gov Identifier: NCT00068120 - Recruiting
  Urinary Tract Infection
  
• ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence
  ClinicalTrials.gov Identifier: NCT00069368 - Recruiting
  Urinary Incontinence; Diabetes
  
• OSHES - Observational Study on Hemostasis in Surgery
  ClinicalTrials.gov Identifier: NCT00279383 - Active, not recruiting
  Blood Loss, Surgical
  
• OSI-774 (Tarceva) in Treating Patients with Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00036647 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
  ClinicalTrials.gov Identifier: NCT00040183 - Completed
  Pancreatic Cancer
  
• OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00193154 - Completed
  Kidney Cancer
  
• OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00230126 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• OSI-774 to Treat Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027313 - Completed
  Breast Neoplasms
  
• OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
  ClinicalTrials.gov Identifier: NCT00076310 - Active, not recruiting
  Head and Neck Cancer
  
• OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00081237 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• OSI-7904L in Patients with Gastric or Gastroesophageal (GEJ) Cancer
  ClinicalTrials.gov Identifier: NCT00073502 - Completed
  Gastroesophageal Adenocarcinoma; Gastric Adenocarcinoma
  
• OSI-7904L versus 5-Fluorouracil/Leucovorin (5-FU/LV) as Treatment in Patients with Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00088270 - Completed
  Bilary Tract Cancer
  
• OSIRIS:Opposing Step-by-Step Insulin Reinforcement to Intensified Strategy
  ClinicalTrials.gov Identifier: NCT00174642 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Oslo Antioxidant Study
  ClinicalTrials.gov Identifier: NCT00520819 - Completed
  Cardiovascular Disease
  
• Oslo Balloon Angioplasty Versus Conservative Treatment
  ClinicalTrials.gov Identifier: NCT00222196 - Completed
  Peripheral Vascular Disease
  
• OSRA - Objective Study in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00451971 - Completed
  Arthritis, Rheumatoid
  
• Osseous Setting Improvement With co-Implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow
  ClinicalTrials.gov Identifier: NCT00557635 - Not yet recruiting
  Tibia or Femur Pseudo-Arthrosis
  
• Osteoarthritis Initiative (OAI): A Knee Health Study
  ClinicalTrials.gov Identifier: NCT00080171 - Active, not recruiting
  Osteoarthritis; Knee Osteoarthritis
  
• Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00120900 - Completed
  Osteoarthritis
  
• Osteoarthritis: Weakness from Inflammation
  ClinicalTrials.gov Identifier: NCT00104312 - Recruiting
  Osteoarthritis
  
• Osteoconductor Potential of an Injectable Calcium Phosphate in Orthopaedic Surgery in Fillings of Osseous Defects
  ClinicalTrials.gov Identifier: NCT00206791 - Recruiting
  Bone Defect
  
• Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00159419 - Recruiting
  Osteogenesis Imperfecta; Osteoporosis; Juvenile Pagets
  
• Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects
  ClinicalTrials.gov Identifier: NCT00426244 - Recruiting
  Low Back Pain; Pregnancy
  
• Osteopathic Manipulative Treatment and Its Relationship to Autonomic Nervous System Activity
  ClinicalTrials.gov Identifier: NCT00516984 - Active, not recruiting
  Healthy
  
• Osteopathic Manipulative Treatment for Post-Operative Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00387361 - Recruiting
  Postoperative Nausea and Vomiting
  
• Osteopathic Otitis Media Research Study
  ClinicalTrials.gov Identifier: NCT00520039 - Recruiting
  Otitis Media With Effusion
  
• Osteopenia and Renal Osteodystrophy: Evaluation and Management
  ClinicalTrials.gov Identifier: NCT00108394 - Active, not recruiting
  Osteopenia; Renal Osteodystrophy
  
• Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00231127 - Recruiting
  COPD; Osteoporosis; Osteopenia
  
• Osteoporosis and Colles Fracture
  ClinicalTrials.gov Identifier: NCT00225004 - Terminated
  Previous or Actual Colles Fracture
  
• Osteoporosis Coordinator for Low Volume Community Hospitals
  ClinicalTrials.gov Identifier: NCT00511693 - Recruiting
  Osteoporosis; Fragility Fractures
  
• Osteoporosis Disease Management Demonstration Project
  ClinicalTrials.gov Identifier: NCT00145067 - Active, not recruiting
  Osteoporosis
  
• Osteoporosis Disease Management Demonstration Project
  ClinicalTrials.gov Identifier: NCT00139425 - Active, not recruiting
  Osteoporosis
  
• Osteoporosis in Children and Adults following Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00008788 - Active, not recruiting
  Osteoporosis; Liver Transplantation
  
• Osteoporosis in Children With ALL
  ClinicalTrials.gov Identifier: NCT00330538 - Completed
  Leukemia, Lymphocytic, Acute, L1
  
• Osteoporosis Prevention After Heart Transplant
  ClinicalTrials.gov Identifier: NCT00000412 - Completed
  Osteoporosis; Cardiac transplantation
  
• Osteoporosis Prevention in Preadolescent Girls
  ClinicalTrials.gov Identifier: NCT00000413 - Completed
  Osteoporosis
  
• Osteoporosis Prevention With Low Dose Alendronate
  ClinicalTrials.gov Identifier: NCT00463268 - Not yet recruiting
  Osteopenia
  
• Osteoporosis Prevention: Changes to Exercise and Diet in Children
  ClinicalTrials.gov Identifier: NCT00063050 - Active, not recruiting
  Osteoporosis
  
• Osteoporosis-School
  ClinicalTrials.gov Identifier: NCT00224991 - Completed
  Osteoporosis
  
• Osteopuncture for Osteoarthritis-Associated Knee Pain & Disability
  ClinicalTrials.gov Identifier: NCT00417313 - Completed
  Osteoarthritis
  
• Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
  ClinicalTrials.gov Identifier: NCT00001217 - Completed
  Osteosarcoma
  
• Osteosarcoma1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy For Treatment Of Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00145639 - Active, not recruiting
  Osteosarcoma
  
• OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00306488 - Recruiting
  Bilateral Geographic Atrophy; Age-Related Macular Degeneration; AMD
  
• Other Effects of Fluvastatin Are Investigated
  ClinicalTrials.gov Identifier: NCT00138528 - Active, not recruiting
  Metabolic Syndrome
  
• OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00081055 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials
  ClinicalTrials.gov Identifier: NCT00451139 - Completed
  Malaria
  
• Out Come Study To Define Laboratory Parameters That Are Best Suited to Diagnose Functional Iron Deficiency
  ClinicalTrials.gov Identifier: NCT00495781 - Completed
  Functional Iron Deficiency
  
• Out-of Hospital Resuscitation Study
  ClinicalTrials.gov Identifier: NCT00196248 - Recruiting
  Ventricular Fibrillation; Asystoly; Resuscitation
  
• Out-of-Hospital Cardiopulmonary Resuscitation and AED Feedback
  ClinicalTrials.gov Identifier: NCT00449969 - Recruiting
  Cardiac Arrest; Resuscitation
  
• Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema
  ClinicalTrials.gov Identifier: NCT00390442 - Completed
  Cardiogenic Pulmonary Edema
  
• OUT-OF-HOSPITAL CPAP STUDY
  ClinicalTrials.gov Identifier: NCT00439075 - Completed
  Acute Cardiogenic Pulmonary Edema
  
• Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
  ClinicalTrials.gov Identifier: NCT00518115 - Recruiting
  Type 2 Diabetes
  
• Outcome and Related Factors of Necrotizing Fasciitis of the Limb
  ClinicalTrials.gov Identifier: NCT00538577 - Recruiting
  Necrotizing Fasciitis
  
• Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA
  ClinicalTrials.gov Identifier: NCT00273403 - Recruiting
  HIV Infections
  
• Outcome Following Antidepressant Treatment on Possible Endophenotypes for Major Depression
  ClinicalTrials.gov Identifier: NCT00386841 - Recruiting
  Healthy
  
• Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the Treatment of Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00312533 - Not yet recruiting
  Osteoarthritis, Knee
  
• Outcome Following Orthopaedic Surgery
  ClinicalTrials.gov Identifier: NCT00261066 - Recruiting
  Orthopaedic Surgery
  
• Outcome Following Shoulder Surgery
  ClinicalTrials.gov Identifier: NCT00253864 - Recruiting
  Shoulder Arthroscopy; Rotator Cuff
  
• Outcome Following Surgery to Repair Rotator Cuff Tears
  ClinicalTrials.gov Identifier: NCT00260949 - Recruiting
  Rotator Cuff Tear
  
• Outcome of Crisis Intervention
  ClinicalTrials.gov Identifier: NCT00269139 - Not yet recruiting
  Borderline Personality Disorder; Post-Traumatic Stress Disorder
  
• Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery
  ClinicalTrials.gov Identifier: NCT00140868 - Completed
  Large bowel obstruction
  
• Outcome of Pancreatic Stump Closure Following Resection of Tumors of the Head of the Pancreas.
  ClinicalTrials.gov Identifier: NCT00419614 - Not yet recruiting
  Pancreatic Neoplasms
  
• Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale
  ClinicalTrials.gov Identifier: NCT00251342 - Recruiting
  Depression, Postpartum
  
• Outcome of Small Pupil Phacotrabeculectomy in Persons With Glaucoma and Cataract
  ClinicalTrials.gov Identifier: NCT00434707 - Not yet recruiting
  Glaucoma; Cataract
  
• Outcome Predictors in Acute Brain Injury
  ClinicalTrials.gov Identifier: NCT00163800 - Completed
  Acute Brain Injury
  
• Outcome Study of Complex Distal Radius Fractures
  ClinicalTrials.gov Identifier: NCT00160810 - Recruiting
  all distal radius fractures
  
• Outcome Study of Patients Treated With Translational Cervical Plate Used to Treat Degenerative Disc Disease
  ClinicalTrials.gov Identifier: NCT00443547 - Recruiting
  Degenerative Disc Disease
  
• Outcome Study ONTARGET
  ClinicalTrials.gov Identifier: NCT00034931 - No longer recruiting
  Coronary Disease; Angina Pectoris; Cerebrovascular Accident; Myocardial Infarction
  
• Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
  ClinicalTrials.gov Identifier: NCT00260559 - Recruiting
  Esophagectomy; Esophageal Cancer
  
• Outcomes After Heller Myotomy
  ClinicalTrials.gov Identifier: NCT00519220 - Recruiting
  Achalasia
  
• Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00260572 - Recruiting
  Gastroesophageal Reflux Disease
  
• Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
  ClinicalTrials.gov Identifier: NCT00194558 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy
  ClinicalTrials.gov Identifier: NCT00442000 - Active, not recruiting
  Prostate Cancer
  
• Outcomes Following Medical or Surgical Management of Endocarditis
  ClinicalTrials.gov Identifier: NCT00166023 - Completed
  Endocarditis
  
• Outcomes following myocardial revascularization: on and off cardiopulmonary bypass
  ClinicalTrials.gov Identifier: NCT00032630 - Recruiting
  Ischemic Heart Disease
  
• Outcomes Following Pulmonary Valve Replacement in Adults
  ClinicalTrials.gov Identifier: NCT00276237 - Completed
  Heart Disease, Congenital; Pulmonary Valve Replacement
  
• Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
  ClinicalTrials.gov Identifier: NCT00460434 - Recruiting
  Pelvic Organ Prolapse
  
• Outcomes from an Asthma Disease Management Program
  ClinicalTrials.gov Identifier: NCT00137722 - Active, not recruiting
  Asthma
  
• Outcomes in a Comparison of Manual Penetrating Keratoplasty and the IntraLase® Enabled Keratoplasty
  ClinicalTrials.gov Identifier: NCT00566605 - Active, not recruiting
  Keratoconus
  
• Outcomes in Education and Counseling for HNPCC Testing
  ClinicalTrials.gov Identifier: NCT00001470 - Recruiting
  Colonic Neoplasm; Colonic Polyps; Hereditary Neoplastic Syndrome
  
• Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept
  ClinicalTrials.gov Identifier: NCT00166153 - Terminated
  Cardiac Transplantation
  
• Outcomes in the Palm of Your Hand: Improving the Quality and Continuity of Patient Care
  ClinicalTrials.gov Identifier: NCT00314730 - Active, not recruiting
  Computers, Handheld; Outcomes Assessment, Patient
  
• Outcomes of a DIEP Flap Program
  ClinicalTrials.gov Identifier: NCT00543907 - Recruiting
  Breast Cancer
  
• Outcomes of Anti-HIV Therapy During Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00001093 - Active, not recruiting
  HIV Infections
  
• Outcomes of Children With Congenital Single Ventricle Heart
  ClinicalTrials.gov Identifier: NCT00266968 - Active, not recruiting
  Congenital Disorders
  
• Outcomes of Education and Counseling for BRCA1 Testing
  ClinicalTrials.gov Identifier: NCT00001468 - Completed
  Breast Neoplasms; Ovarian Neoplasms
  
• Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C
  ClinicalTrials.gov Identifier: NCT00346489 - Completed
  Glaucoma
  
• Outcomes of Orthopaedic Surgery Using Gait Laboratory Versus Observational Gait Analysis in Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00419432 - Recruiting
  Cerebral Palsy
  
• Outcomes of Partial Versus Complete Tonsillectomy for Obstructive Sleep Disordered Breathing
  ClinicalTrials.gov Identifier: NCT00519402 - Not yet recruiting
  Partial Versus Complete Tonsillectomy for Obstruction Sleep Disordered Breathing
  
• Outcomes of Patients Not Responding to Antibiotics in the Community
  ClinicalTrials.gov Identifier: NCT00245427 - Completed
  Sinusitis; Bronchitis, Chronic; Pneumonia, Bacterial
  
• Outcomes of Sleep Disorders in Older Men
  ClinicalTrials.gov Identifier: NCT00070681 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Sleep; Sleep Apnea Syndromes; Neurologic Manifestations; Osteoporosis; Bone Diseases
  
• Outcomes Of Social Service Programs For Homebound Older Adults
  ClinicalTrials.gov Identifier: NCT00248924 - Completed
  Homebound; Elderly
  
• Outcomes of Swallowing Rehabilitation After Stroke
  ClinicalTrials.gov Identifier: NCT00288834 - Completed
  Stroke; Cerebrovascular Accident; Dysphagia
  
• Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00524472 - Recruiting
  Cardiac Surgery
  
• Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients
  ClinicalTrials.gov Identifier: NCT00282698 - Completed
  Cardiac Surgical Procedures; Hyperglycemia
  
• Outdoor Allergen Exposure, Sensitivity, and Acute Asthma
  ClinicalTrials.gov Identifier: NCT00043992 - Completed
  Asthma
  
• Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
  ClinicalTrials.gov Identifier: NCT00438685 - Active, not recruiting
  Substance-Related Disorders; Depressive Disorder; Anxiety Disorder
  
• Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics
  ClinicalTrials.gov Identifier: NCT00514618 - Recruiting
  Diabetes, Gestational
  
• Outpatient Evaluation of Patients with Known or Suspected Heart Disease
  ClinicalTrials.gov Identifier: NCT00001400 - Completed
  Heart Disease
  
• Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00317057 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety
  ClinicalTrials.gov Identifier: NCT00256568 - Active, not recruiting
  Medication Errors
  
• Outpatient Registry Trial of Respiratory Tract Infections in Adults
  ClinicalTrials.gov Identifier: NCT00245453 - Terminated
  Pneumonia, Bacterial; Bronchitis, Chronic
  
• Outpatient Treatment Of Deep Venous Thrombosis (DVT) Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
  ClinicalTrials.gov Identifier: NCT00041782 - Terminated
  Neoplasms; Deep Vein Thrombosis
  
• Outpatient Treatment of the Alcohol Withdrawal Syndrome
  ClinicalTrials.gov Identifier: NCT00136617 - Active, not recruiting
  Alcoholism; Alcohol Withdrawal
  
• Outpatient vs Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence. The IN/OUT Study.
  ClinicalTrials.gov Identifier: NCT00226720 - Completed
  Alcoholism; Alcohol Dependence
  
• Outreach and Treatment for Depression in the Labor Force
  ClinicalTrials.gov Identifier: NCT00057590 - Completed
  Depression
  
• Outreach: A Programme for Timely Treatment of Critically Ill Patients in a University Hospital
  ClinicalTrials.gov Identifier: NCT00306345 - Recruiting
  Patient Centered Care; Postoperative Care; Critical Illness
  
• Ovarian Cancer and Immune Response to Flu Vaccine
  ClinicalTrials.gov Identifier: NCT00478387 - Recruiting
  Ovarian Cancer
  
• Ovarian Cancer Patient Questionnaire On Genetic Testing
  ClinicalTrials.gov Identifier: NCT00486707 - Recruiting
  Ovarian Cancer
  
• Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00402935 - Active, not recruiting
  Leukemia; Long-Term Effects Secondary to Cancer Therapy in Adults; Long-Term Effects Secondary to Cancer Therapy in Children; Lymphoma; Sexual Dysfunction and Infertility; Sexuality and Reproductive Issues; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Ovarian Follicle Function in Patients with Premature Ovarian Failure
  ClinicalTrials.gov Identifier: NCT00001275 - Recruiting
  Amenorrhea; Hypoaldosteronism; Hypogonadism; Infertility; Premature Ovarian Failure
  
• Ovarian Screening Study
  ClinicalTrials.gov Identifier: NCT00267072 - Recruiting
  Ovarian Cancer
  
• OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00382811 - Recruiting
  Fallopian Tube Cancer; Peritoneal Neoplasms; Ovarian Cancer
  
• OVCA-NAC-P2: Study of Chemotherapy followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers
  ClinicalTrials.gov Identifier: NCT00112086 - Active, not recruiting
  Ovarian Neoplasms; Fallopian Tube Neoplasms
  
• Over-the-Counter Medication Usage
  ClinicalTrials.gov Identifier: NCT00439348 - Recruiting
  Drugs, Non-Prescription; Medication Systems
  
• Overactive Bladder Innovative Therapy Trial (OrBIT)
  ClinicalTrials.gov Identifier: NCT00448175 - Recruiting
  Overactive Bladder
  
• Overcome Biochemical Aspirin Resistane Through Cilostazol Combination
  ClinicalTrials.gov Identifier: NCT00446641 - Recruiting
  Cerebral Infarction
  
• Overcoming Nutritional Barriers in Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00136253 - Completed
  End Stage Renal Disease
  
• Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
  ClinicalTrials.gov Identifier: NCT00407732 - Recruiting
  Hepatitis C; Substance Use Disorders; Mental Disorder
  
• Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
  ClinicalTrials.gov Identifier: NCT00558025 - Recruiting
  Parkinson Disease
  
• Overweight Adults--Ethnic, SES and Behavioral Influences
  ClinicalTrials.gov Identifier: NCT00005752 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Overweight and Obesity Control At Worksites
  ClinicalTrials.gov Identifier: NCT00123019 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Oxalipatin - Rectal Neoplasms
  ClinicalTrials.gov Identifier: NCT00421824 - Recruiting
  Rectal Neoplasms
  
• Oxaliplatin + 5-FluoroUracil/LeucoVorin(5-FU/LV) (FOLFOX4) vs Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00471965 - Recruiting
  Carcinoma, Hepatocellular
  
• Oxaliplatin and 5-FU Based Preoperative Chemoradiation
  ClinicalTrials.gov Identifier: NCT00278694 - Recruiting
  Rectal Cancer
  
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00062426 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
  
• Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00066625 - Completed
  unspecified adult solid tumor, protocol specific
  
• Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193609 - Recruiting
  Neoplasms, Unknown Primary
  
• Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00040859 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00448552 - Active, not recruiting
  Head and Neck Cancer
  
• Oxaliplatin and Capecitabine Versus Follow-Up After Resection of Colorectal Liver Metastases
  ClinicalTrials.gov Identifier: NCT00156975 - Active, not recruiting
  Colorectal Neoplasms; Liver Metastases
  
• Oxaliplatin and Capecitabine With or Without Hepatic Arterial Infusion of Floxuridine in Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00268463 - Active, not recruiting
  Liver Metastases; Stage IV Colon Cancer; Stage IV Rectal Cancer; Adenocarcinoma of the Colon; Adenocarcinoma of the Rectum
  
• Oxaliplatin and Cetuximab in First-Line Treatment of mCRC
  ClinicalTrials.gov Identifier: NCT00125034 - Active, not recruiting
  first-line MCRC; EGFR positive; metastatic CRC
  
• Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00557206 - Recruiting
  Neoplasms; Head and Neck Neoplasms
  
• Oxaliplatin and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00101205 - Suspended
  Cancer
  
• Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004206 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004257 - Completed
  stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage I gastric cancer; ...
  
• Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
  ClinicalTrials.gov Identifier: NCT00476086 - Recruiting
  Mullerian Tumors of the Uterus
  
• Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004220 - Completed
  unspecified adult solid tumor, protocol specific
  
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00101270 - Completed
  Cancer
  
• Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00057863 - Recruiting
  recurrent cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer; cervical adenosquamous cell carcinoma; ...
  
• Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
  ClinicalTrials.gov Identifier: NCT00004173 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
  ClinicalTrials.gov Identifier: NCT00491855 - Recruiting
  Peritoneal Cancer
  
• Oxaliplatin and Topotecan in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00313612 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00006391 - Active, not recruiting
  recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Oxaliplatin in Cancer Patients with Impaired Kidney Function
  ClinicalTrials.gov Identifier: NCT00001835 - Completed
  Kidney Disease; Neoplasm; Neoplasm Metastasis
  
• Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00268151 - Terminated
  Carcinoma, Non-Small Cell Lung
  
• Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
  ClinicalTrials.gov Identifier: NCT00259402 - Recruiting
  Esophageal Neoplasms
  
• Oxaliplatin in Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00263354 - Completed
  Stomach Neoplasms
  
• Oxaliplatin in Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00259363 - Terminated
  Rectal Neoplasms
  
• Oxaliplatin in Treating Children With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005844 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
  ClinicalTrials.gov Identifier: NCT00047177 - Completed
  recurrent childhood medulloblastoma; recurrent childhood supratentorial primitive neuroectodermal tumors; recurrent childhood ependymoma; ...
  
• Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00005077 - Completed
  unspecified adult solid tumor, protocol specific
  
• Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005035 - Completed
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Oxaliplatin in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00052364 - Active, not recruiting
  advanced adult primary liver cancer; localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004203 - Active, not recruiting
  transitional cell carcinoma of the bladder; recurrent bladder cancer; stage IV bladder cancer; ...
  
• Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00071929 - Completed
  recurrent endometrial cancer
  
• Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00040820 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00017082 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00005837 - Completed
  recurrent cervical cancer; cervical squamous cell carcinoma
  
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00005836 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006473 - Completed
  Waldenstrom's Macroglobulinemia; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; angioimmunoblastic T-cell lymphoma
  
• Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006121 - Active, not recruiting
  stage III breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00091182 - Active, not recruiting
  Cancer
  
• Oxaliplatin in Unresectable Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00280618 - Completed
  Carcinoma, Hepatocellular
  
• Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
  ClinicalTrials.gov Identifier: NCT00019773 - Completed
  Carcinoma of the Appendix; Colorectal Cancer; Small Intestine Cancer
  
• Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
  ClinicalTrials.gov Identifier: NCT00005839 - Completed
  unspecified adult solid tumor, protocol specific
  
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00003427 - Active, not recruiting
  Pancreatic Cancer; Colon Cancer; Gastric Cancer; Rectal Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer
  
• Oxaliplatin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00005856 - Completed
  adult glioblastoma
  
• Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00006062 - Completed
  Liver Disease
  
• Oxaliplatin With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00004127 - Completed
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
  ClinicalTrials.gov Identifier: NCT00005860 - Completed
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; adult primary liver cancer; ovarian epithelial cancer; Colon Cancer
  
• Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00026299 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Oxaliplatin, 5-FU and Leucovorin in Combination With Oral Capecitabine for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00205322 - Completed
  Metastatic Colorectal Cancer
  
• Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00408772 - Not yet recruiting
  Colorectal Cancer; Metastatic Cancer
  
• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
  ClinicalTrials.gov Identifier: NCT00483405 - Recruiting
  Liver Cancer
  
• Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00470184 - Recruiting
  Esophageal Cancer
  
• Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
  ClinicalTrials.gov Identifier: NCT00086931 - Completed
  adenocarcinoma of the rectum; stage III rectal cancer; stage II rectal cancer
  
• Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stomach Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00335959 - Recruiting
  Gastric Cancer
  
• Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00383695 - Recruiting
  Colorectal Cancer
  
• Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II or Stage III or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00356941 - Recruiting
  Lung Cancer
  
• Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00480987 - Recruiting
  Myelodysplastic Syndromes; Acute Myeloid Leukemia; Leukemia
  
• Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
  ClinicalTrials.gov Identifier: NCT00452374 - Active, not recruiting
  Leukemia
  
• Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
  ClinicalTrials.gov Identifier: NCT00472849 - Recruiting
  Richter's Transformation; Leukemia
  
• Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
  ClinicalTrials.gov Identifier: NCT00006094 - Completed
  stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Oxaliplatin, Fluorouracil, and Leucovorin With or Without PTK787/ZK 222584 in Treating Patients With Refractory or Recurrent Metastatic Colon or Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00068679 - No longer recruiting
  adenocarcinoma of the rectum; adenocarcinoma of the colon; stage IV colon cancer; recurrent colon cancer; Stage IV rectal cancer; ...
  
• Oxaliplatin, Fluorouracil, Erlotinib, and Radiation Therapy Before Surgery and Erlotinib After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00499564 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Oxaliplatin, Fluorouracil, Radiation Therapy, and Surgery in Treating Patients With Stage II or Stage III Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00086996 - Recruiting
  Adenocarcinoma of the Esophagus; stage II esophageal cancer; stage III esophageal cancer
  
• Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00093652 - Active, not recruiting
  Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
  
• Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
  ClinicalTrials.gov Identifier: NCT00418093 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
  
• Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00266097 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
  
• Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00217711 - Active, not recruiting
  Colorectal Cancer
  
• Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Metastatic or Inoperable Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00084617 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00217737 - Recruiting
  Colorectal Cancer
  
• Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma
  ClinicalTrials.gov Identifier: NCT00525915 - Recruiting
  Esophageal Cancer; Gastroesophageal Cancer
  
• Oxaliplatin-Oesophageal Cancer
  ClinicalTrials.gov Identifier: NCT00160030 - Active, not recruiting
  Esophageal Neoplasms
  
• Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00316433 - Terminated
  Small Cell Lung Cancer
  
• Oxaliplatine and Docetaxel as Firstline Therapy for Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00145418 - Recruiting
  Non small Cell Lung Cancer Stage IIIb and IV
  
• Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
  ClinicalTrials.gov Identifier: NCT00004275 - Active, not recruiting
  Turner's Syndrome
  
• Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00070148 - Active, not recruiting
  Quality of Life; weight changes; unspecified adult solid tumor, protocol specific
  
• Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
  ClinicalTrials.gov Identifier: NCT00243399 - Recruiting
  Fanconi Anemia
  
• Oxcarbazepine Versus Placebo in Childhood Autism
  ClinicalTrials.gov Identifier: NCT00467753 - Recruiting
  Autism
  
• Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function
  ClinicalTrials.gov Identifier: NCT00232531 - Active, not recruiting
  Atherosclerosis
  
• Oxford® Partial Knee Kinematics Gait Analysis Study
  ClinicalTrials.gov Identifier: NCT00576966 - Recruiting
  Medial Compartment Arthritis
  
• Oxidative Stress and Cardiovascular Morbidity in SAHS
  ClinicalTrials.gov Identifier: NCT00487929 - Recruiting
  Sleep Apnea; Cardiovascular Diseases
  
• Oxidative Stress and Hemodialysis Access Failure
  ClinicalTrials.gov Identifier: NCT00410449 - Completed
  End Stage Renal Disease; Hemodialysis
  
• Oxidative Stress and Vitamin E Requirements
  ClinicalTrials.gov Identifier: NCT00067899 - Completed
  Smoking
  
• Oxidative Stress in Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00069810 - Recruiting
  Cardiovascular Diseases; Heart Diseases; Kidney Failure, Chronic
  
• Oxidative Stress in Patients With Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00465400 - Recruiting
  Macular Degeneration
  
• Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
  ClinicalTrials.gov Identifier: NCT00404599 - Not yet recruiting
  Diabetes Mellitus; Hypertension
  
• Oxidized Glutathione (NOV-002), Doxorubicin, Cyclophosphamide, and Docetaxel in Treating Women With Newly Diagnosed Stage IIB, or Stage IIIC Breast Cancer
  ClinicalTrials.gov Identifier: NCT00499122 - Recruiting
  Breast Cancer
  
• OXY-1: The Pharmacogenetics of Oxycodone Analgesia in Postoperative Pain
  ClinicalTrials.gov Identifier: NCT00260260 - Recruiting
  Postoperative Pain
  
• OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
  ClinicalTrials.gov Identifier: NCT00271973 - Completed
  Healthy Volunteer.
  
• Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
  ClinicalTrials.gov Identifier: NCT00378937 - Active, not recruiting
  Pain; Unspecified Adult Solid Tumor, Protocol Specific
  
• Oxycodone vs Fentanyl for Pain Treatment After Laparoscopic Cholecystectomy
  ClinicalTrials.gov Identifier: NCT00369811 - Completed
  Pain
  
• Oxycodone-Naloxone in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412152 - Active, not recruiting
  Pain
  
• Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
  ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
  Pain
  
• Oxygen Therapy in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00525863 - Not yet recruiting
  Chronic Schizophrenia
  
• Oxygen Toxicity in the Resuscitation in Extremely Premature Infants
  ClinicalTrials.gov Identifier: NCT00494702 - Recruiting
  Asphyxia Neonatorum; Premature Birth
  
• Oxygen Treatment in Heart Failure
  ClinicalTrials.gov Identifier: NCT00338078 - Completed
  Heart Failure
  
• Oxygen Uptake Kinetics During Recovery from Maximal and Submaximal Exercise
  ClinicalTrials.gov Identifier: NCT00001519 - Completed
  Healthy
  
• Oxypurinol compared with Placebo for Class III-IV NYHA Congestive Heart Failure
  ClinicalTrials.gov Identifier: NCT00063687 - Completed
  Congestive Heart Failure
  
• Oxytocin Add on Study for Stable Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00506909 - Not yet recruiting
  Schizophrenia
  
• Oxytocin Administration in the Third Stage of Labour - A Study of Appropriate Route and Dose
  ClinicalTrials.gov Identifier: NCT00200252 - Completed
  Third Stage of Labour
  
• Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00360048 - Completed
  Sepsis
  
• Ozone and Rhinovirus-Induced Disease in Asthmatics
  ClinicalTrials.gov Identifier: NCT00013715 - Recruiting
  Asthma
  
• Ozone Exposure and Dose Delivered to Human Lungs
  ClinicalTrials.gov Identifier: NCT00013780 - Completed
  Lung Disease